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Abstract 
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is frequently co-diagnosed with 
other functional pain disorders, most significantly interstitial cystitis/painful bladder syndrome 
(IC/PBS), as well as mood disorders, particularly depression and/or anxiety. Patients suffering 
from functional pain disorders frequently report a history of early life stress, which has been 
associated with maladjusted stress response in adulthood. Basal function of the hypothalamic-
pituitary-adrenal (HPA) axis, a major neuroendocrine stress response system, is programed 
during this critical period of development. Regular voluntary exercise has been shown to have a 
beneficial impact on depression and anxiety, as well as decreased perceptions of pain 
associated with HPA axis dysfunction in clinical and pre-clinical studies; however, to our 
knowledge, exercise has not been investigated as a potential intervention for comorbid 
urogenital pain disorders. This project reports neonatal maternal separation (NMS) induced 
mechanical perigenital allodynia, increased susceptibility to experimental colitis, altered 
micturition patterns, increased mast cell degranulation, and decreased HPA axis output. NMS 
did not, however, result in anxiety-like nor depression-like behaviors. Acute adult stress did 
significantly impact some of these measures, but did not enhance the effect of NMS. Lastly, we 
did see improvement of perigenital sensitivity following early and late exercise interventions, but 
did see more robust improvements in behavioral measurements after early exercise than late 
exercise. Late exercise, however, made a greater impact on central gene expression changes in 
limbic structures involved in HPA axis activity. Here, I have provided novel insight into the 
mechanisms potentially underlying significantly debilitating chronic pelvic pain disorders 
following early life stress, as well as evidence on the efficacy of therapeutic exercise, an easily 
translatable intervention, as a potential treatment strategy for these comorbid disorders. This 
work presents the first evidence of the impact of exercise on the effects of NMS on male mice, 
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Chapter I: Introduction 
Visceral pain 
The International Association for the Study of Pain (IASP) defines ‘pain’ as an 
“unpleasant sensory and emotional experience associated with actual or potential tissue 
damage or described in terms of such damage” [1]. A particularly vexing type of pain for both 
patients and healthcare providers is chronic visceral or pelvic pain; pain that is localized to the 
lower abdomen and the pelvic and perineal regions. Chronic pelvic and urogenital pain is 
common and debilitating, and is the foremost complaint of patients suffering from functional 
bowel disorders (e.g., irritable bowel syndrome; IBS) and chronic pelvic pain disorders (e.g., 
interstitial cystitis, painful bladder syndrome; IC/PBS); moreover, this type of pain is idiopathic, 
meaning the etiologies of these painful disorders are unknown and are not associated with 
identifiable infectious, anatomical, metabolic, or other organic pathologies. The mechanisms of 
chronic visceral pain are poorly understood, in part due to its diffuse and poorly localized nature, 
often confused or overlapping between two visceral organs. Additionally, the diverse nature of 
visceral pain is compounded by multiple factors, including psychosocial stress, sexual 
dimorphism, and genetic and/or environmental predisposition. These multiple contributing 
factors make treatment and research efforts, especially the development and study of relevant 
animal models, challenging. 
Despite its multifaceted nature, visceral hypersensitivity has been recognized to occur 
due to (1) sensitization of primary sensory afferents innervating the viscera (peripheral 
sensitization), (2) hyper-excitability of ascending spinal neurons receiving synaptic input from 
the viscera (central sensitization), and (3) dysregulation of descending pathways that modulate 
spinal nociceptive transmission [2]. For the purposes of this work, we will focus on the 
descending pathway and feedback loop of the hypothalamic-pituitary-adrenal (HPA) axis, as 
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well as its contribution to IBS, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and 
IC/PBS.  
Irritable bowel syndrome 
Irritable bowel syndrome (IBS) is the most commonly diagnosed chronic pelvic pain 
disorder, as well as functional gastrointestinal disorder. IBS is characterized by chronic or 
recurrent abdominal pain or discomfort and altered bowel habits. IBS is estimated to impact 
approximately 20% of the US population and cost up to $30 billion in direct and indirect medical 
expenses annually [3, 4]. Like most functional pain disorders, IBS is diagnosed in twice as many 
women than men [5], and co-diagnosis with other chronic pelvic pain conditions is markedly 
high; up to 80% of IBS patients also present with symptoms of CP/CPPS, IC/PBS, and 
vulvodynia [6-11]. Additionally, up to 60% of IBS patients also suffer from anxiety and/or 
depression [12]. Moreover, a Norwegian study reported IBS patients with comorbid 
symptomology to have healthcare costs ten times that of patients with IBS alone [13].  
A prominent symptom of IBS, and the main reason patients seek medical care, is 
visceral hypersensitivity (VH), which is defined by altered sensation of normal physiological 
stimuli (allodynia) and enhanced perception of mechanical stimulus to the abdominal region 
(hyperalgesia) [14]. The underlying mechanism contributing to VH is likely multifactorial and has 
been shown to involve inflammation, psychosocial stress, and peripheral and central 
sensitization of nociceptive input [14]. Symptom onset or exacerbation is often triggered by 
stress in patients suffering from IBS [12, 15-18]. A reported history of early life stress, such as 
premature birth, neglect, abuse, loss of a parent or parental discord, is a significant risk factor 
for developing IBS in adulthood [19-21].  This is thought to be due to perturbations in proper 
functioning of the HPA axis, particularly over activity, as it has been noted in sub-populations of 
IBS sufferers [21, 22]. A potential role for corticotropin-releasing factor (CRF; a key signaling 
hormone within the HPA axis) in mediating comorbidity between psychological and chronic pain 
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disorders has been investigated in both clinical and preclinical settings. Over-activity of central 
corticotropin-releasing factor receptor 1 (CRF1) signaling has been proposed to contribute 
towards comorbid anxiety/depression in female diarrhea-predominant IBS patients [23]. 
However, antagonist inhibition of CRF1 activity has had mixed success in patients depending on 
IBS sub-type, such has high-anxiety and generalized diarrhea-predominant IBS [24, 25]. These 
studies emphasize the heterogeneity of etiology underlying IBS, despite similar symptomology. 
Further understanding of IBS and comorbidities will be essential in designing appropriate, 
personalized treatment strategies. 
Because of the significant impact of early life stress on IBS development, a frequently 
utilized research model is neonatal maternal separation (NMS) in rodents, particularly rats. NMS 
will be explored in greater detail later within this chapter. NMS-exposed rodents exhibit many 
colorectal sensitivity, functional, and neuroimmune abnormalities observed in human cases. 
Colorectal sensitivity is assessed by measuring abdominal muscle contraction, termed 
visceromotor response (VMR), during colorectal balloon distention (CRD). Rodents exposed to 
NMS demonstrate increased growth factor and cytokine expression, including nerve growth 
factor (NGF), interleukin 6 (IL-6), IL-1, IL-2, IL-4, IL-10, and interferon (IFN)- [26-29], as well 
as infiltration of mast cells [30-32], in the distal colon, all of which can sensitize peripheral 
nociceptors and enhance visceral perception [26-29, 33]. Mast cell infiltration and hypertrophy of 
sensory innervation has also been reported in biopsies from patients with IBS [34-36].  
Chronic prostatitis/chronic pelvic pain syndrome 
 After convening two international consensus conferences, the National Institutes of 
Health (NIH) established a new definition and a four-category classification system of prostatitis 
syndromes [37]. Table 1 outlines these categories and their defining characteristics. Categories 
I (acute bacterial) and II (chronic bacterial) prostatitis are well-defined and usually resolve after 
antimicrobial therapy, but only account for less than 10% of prostatitis cases [38]. Category IV, 
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Table 1: Classification of prostatitis syndromes [37] 
Category Name Characteristics 
I Acute bacterial prostatitis 
 Acute bacterial, urinary tract infection 
 Increased urinary frequency and dysuria 
 Systemic infection, bacteriuria, and 
pyuria 
II Chronic bacterial prostatitis 
 Persistent and/or recurrent bacterial, 
UTI 
III 
Chronic prostatitis/chronic pelvic pain 
syndrome (CP/CPPS) 
 Pelvic and urological pain, urinary 
complaints, and sexual dysfunction 
 Absence of other urological diseases or 
disorders 
IIIa Inflammatory CP/CPPS 
 Leukocytes present in expressed 
prostatic secretions, post-prostate 
massage urine, or seminal fluid 
IIIb Noninflammatory CP/CPPS  
 No evidence of inflammation in 
expressed secretions, post-prostate 
massage urine, or seminal fluid 
IV Asymptomatic inflammatory prostatitis 
 No history of genitourinary tract pain 
complaints  
 Inflammatory infiltrates in prostate tissue 
or secretions/fluids found during 





asymptomatic prostatitis, is usually only discovered while patients are undergoing evaluation for 
prostate cancer, infertility, or other genitourinary tract issues. Category III chronic prostatitis 
(CP/CPPS) is further divided into inflammatory and noninflammatory subtypes based on the 
presence or absence of leukocytes in prostatic secretions. There is currently no single 
diagnostic test for CP/CPPS, but is rather diagnosed after ruling out other urogenital diseases or 
disorders. The NIH chronic prostatitis symptom index (NIH-CPSI) is a questionnaire that 
captures the three most significant domains of chronic prostatitis: pain (location, frequency, and 
severity), voiding (irritative/storage and obstructive/voiding symptoms), and quality of life 
(including impact). The NIH-CPSI is a valuable and reliable tool used in clinical practice and 
research settings [38, 39]. Patients with pain duration of less than 3 months, lower genitourinary 
tract cancer (e.g., prostate cancer), gastrointestinal disorders (e.g., inflammatory bowel 
disease), active urolithiasis or urinary tract infection, radiation of chemical cystitis, acute 
urethritis, acute epididymitis, acute orchitis, functionally significant urethral stricture disease, or 
neurological disorder affecting the bladder are excluded from a CP/CPPS diagnosis [40].  
On average, it’s estimated 8.2% men experience prostatitis symptoms annually in the 
United States, ranging between a prevalence rate of 2.2% to 9.7% [40] (9% of men in Canada 
[38]) and a life time prevalence near 14% [41].  Of the four clinically-defined categories of 
prostatitis, category III CP/CPPS is the most prevalent at a rate approximated to be 6-12% [42] 
and accounting for 90% of all chronic prostatitis cases [37, 43]. CP/CPPS is the most common 
urological diagnosis among men under the age of 50, as well as the third most common among 
those over 50 [44, 45], accounting for 2 million outpatient visits recorded annually in the United 
States [42, 46, 47]; approximately 8% of urology office visits in the US [48] and about 3% of 
male outpatient visits in Canada [38]. The estimated annual cost to treat prostatitis, due to 
increased outpatient visits and pharmacy expenses, is $84 million [44, 47]; annual patients’ 
costs are approximated to be $4,400, twice that estimated for low back pain or rheumatoid 
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arthritis [47]. CP/CPPS is characterized by chronic, idiopathic pain in the lower abdomen, 
rectum, perineum, prostate, penis, and/or testicles with or without urinary symptoms [44, 45] 
and is diagnosed symptomatically due to the lack of associated pathology [49]. CP/CPPS has 
detrimental effects on quality of life, comparable to myocardial infarction, angina, Crohn’s 
disease, and diabetes [45, 50].  
Published rodent models of CP/CPPS require experimental infection; injection of 
exogenous antigens, androgens or irritants; or invasive surgery [46] and, as such, are largely 
undefined in their mechanism of CP/CPPS development. A spontaneous rat model of prostatitis 
has been reported; however, it requires 20-24 weeks [51, 52] or 40-52 weeks [53] before 
symptoms are observed. Possibly the most common rodent model is the experimental 
autoimmune prostatitis (EAP) model; complete Freund’s adjuvant (CFA) is injected 
subcutaneously to produce abdominal/pelvic hypersensitivity. CFA is a solution of carrageenan 
in saline widely used to induce swelling and hypersensitivity in a variety of inflammatory models; 
however, studies utilizing the EAP model have resulted in varied degrees of prostatic 
inflammation depending on the species and strain used [43, 54-57]. Another rodent model 
initiates direct inflammation of the prostate by intraorgan injection of zymosan either once or 
several times [58, 59]. Proposed mouse models, however, have lacked translational potential 
due to unclear mechanisms of action, nonspecific results, high mortality, and/or lack of 
validation [46].   
Interstitial cystitis/Painful bladder syndrome 
 Similar to CP/CPPS, IC/PBS is characterized by idiopathic pelviperineal pain and 
increased urinary urgency and frequency. IC/PBS is also diagnosed based on symptoms, 
particularly irritative voiding and referred lower urinary tract pain, after excluding other 
pathologies that mimic symptoms of IC/PBS (e.g., urinary tract infection). According to the 
Interstitial Cystitis Association (ICA), IC/PBS impacts 3 to 8 million women (3-6% of all women 
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in the US) and 1 to 4 million men in the United States [60]. Other sources have estimated as 
high as 11% of women and 5% of men in the US meet the high sensitivity definition of IC/PBS 
[61-63]. Patients’ direct medical costs for treatment are estimated to be about $4000 annually 
[64], translating to roughly $20 to $40 billion a year spent in the US alone.  
IC, before it became the more encompassing IC/PBS, only referred to observable 
findings of tissue damage (i.e., Hunner’s ulcers, glomerulations, and overt histopathology) [65, 
66]; however, studies have revealed the population to be more heterogeneous than the strict 
criteria used for research qualifications. IC/PBS, like many idiopathic pain disorders, is 
considered polysyndromic and patients may exhibit one of multiple subtypes differentiated by 
additional features [67]. For example, IC/PBS can be further divided into ulcerative and non-
ulcerative subtypes. This is determined by the presence of Hunner’s ulcers or glomerulations 
(submucosal hemorrhages) without ulcers on the bladder wall identified during cystoscopic 
examination; however, about 10% of patients show no signs of Hunner’s ulcers or 
glomerulations [68]. The reliance on cystoscopic criteria may be one reason IC/PBS is 
considered to be underdiagnosed. Today, diagnoses require (1) pain/discomfort for a duration 
equal to or greater than 6 weeks, (2) pain/discomfort perceived to be related to the urinary 
bladder, (3) at least one additional urological symptom (urgency and/or frequency), and (4) 
these symptoms cannot be attributed to other known causes of bladder pain (e.g., infection or 
organic disease) [65-67, 69]. 
 A variety of possible etiologies have been proposed over the years, and, when taken 
together, suggest a cyclical cascade of events involving neurogenic inflammation, hyper-
responsive immune system, urothelial lining leakage/dysfunction, and chronic pain; however, 
the primary insult that initiates IC/PBS pathophysiology is unclear [70]. Though the prodome has 
not yet been identified, several urine biomarkers have been associated with IC/PBS, including 
IL-6 [71-74], histamine [73], and nerve growth factor (NGF) [75, 76].  
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 Using rodent models, intravesicular irritant injection has been used to study the effect 
neonatal bladder irritation on bladder sensitivity and function. Rats subjected to zymosan 
irritation have displayed increased visceromotor response (VMR) during urinary bladder 
distention (UBD), increased micturition frequency with decreases in volume thresholds, and 
increased plasma extravasation and neuropeptide release after intravesicular mustard oil 
application [77, 78]. Other rodent models of stress-induced bladder hypersensitivity will be 
discussed later in this chapter. 
Co-morbidities 
As previously mentioned, the etiology of CP/CPPS is unknown and patients frequently 
present with symptoms of or are co-diagnosed with other functional somatic syndromes and/or 
mood disturbances (e.g., anxiety and depression) [8, 79-84]. CP/CPPS patients are frequently 
diagnosed with comorbid IBS (35%), chronic headache (36%), fibromyalgia (5%), and 
psychological disorders (48%) [80]. Similarly, approximately 40% of IC/PBS patients suffer 
comorbid chronic pelvic pain disorders [3, 8, 9, 85], and a significant proportion also suffer from 
fibromyalgia, allergies, and mood disorders [6, 79, 86-89]. Associations between anxiety and 
voiding disorders have also been reported [90] and interstitial cystitis (IC) patients with 
fibromyalgia, chronic fatigue syndrome, or rheumatoid arthritis had higher mean afternoon 
cortisol levels and increased pain during bladder filling than IC patients with no additional 
diagnoses [91]. Furthermore, there is an estimated 17% overlap between patients diagnosed 
with CP/CPPS and IC/PBS when considering only those patients that met the high sensitivity 
criteria for research qualification, meaning the diagnostic overlap of these syndromes may 
actually be greater [79]. As with CP/CPPS, current treatments for IC/PBS are largely 
unsatisfactory [80] and the high comorbidity between the two syndromes creates an even 
greater negative impact on quality of life, complicating already less-than-ideal treatment 
strategies [80, 89]. Not only is it difficult to treat the painful syndrome(s), it is also significantly 
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more difficult to treat depression symptoms in patients suffering from concomitant chronic pain 
[92]. 
The Interstitial Cystitis Association asserts the number of men affected by IC/PBS may 
be greater than currently estimated because it is often ‘mistaken’ for CP/CPPS; similarly, more 
recent studies have revealed CP/CPPS symptoms to be more widespread than previously 
thought, thus contributing to its under-diagnosis in the United States [63, 93]. Several 
investigators, however, have proposed IC/PBS and CP/CPPS to be different manifestations of 
the same underlying syndrome [93-98]. CP/CPPS and IC/PBS share multiple symptoms, 
specifically pelviperineal pain and urinary symptoms, and are frequently co-diagnosed [63, 65]. 
To further illustrate the overlap between these syndromes, cystoscopic findings of 
glomerulations in the bladder, a diagnostic symptom of IC/PBS, are also present for up to 70% 
of men with CP/CPPS, supporting the possibility that CP/CPPS and IC/PBS are one and the 
same [98].  
Patients suffering from CP/CPPS often experience higher perceptions of stress, which 
can trigger or worsen ongoing symptoms [99, 100]; similarly, symptom onset and increased 
severity during periods of heightened stress are hallmarks of IC/PBS [11, 81]. Comorbid mood 
and pelvic pain disorders have been associated with disruption in proper functioning and limbic 
regulation of the hypothalamic-pituitary-adrenal (HPA) axis, which utilizes corticotropin-releasing 
factor (CRF) to regulate stress response and influence the perception of pain [21, 101-105]. 
Hypothalamic-pituitary-adrenal axis 
The key system in the stress response is the hypothalamic-pituitary-adrenal (HPA) axis. 
In response to stress, the neurons in the paraventricular nucleus (PVN) of the hypothalamus 
secrete corticotropin-releasing factor (CRF) and arginine vasopressin (AVP). This triggers the 
subsequent release of adrenocorticotropic hormone (ACTH) from the anterior pituitary, which in 
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turn signals the production of glucocorticoids (cortisol in humans, corticosterone in rodents) by 
the adrenal cortex. Similarly, family members urocortin (Ucn) 2 and Ucn3 are produced in 
stress-related brain regions, including the PVN [106, 107]; however, Ucn1 is largely expressed 
in Edinger-Westphal, superior lateral olive, and supraoptic nuclei [108, 109]. When the 
perceived stressor has subsided, feedback loops at various levels of the system (pituitary, 
hypothalamus, hippocampus, frontal cortex) trigger the shutdown of the HPA axis and a return 
to homeostasis through the activation of CRF receptors (CRF1 and CRF2) and the glucocorticoid 
receptors (glucocorticoid receptor (GR) and mineralocorticoid receptor (MR)) [110-113]. 
Activation of CRF1 and CRF2 work in opposition of one another, driving and dampening HPA 
output, respectively [114-117]. CRF binds CRF1 with a 10-fold higher affinity than CRF2, Ucn1 
binds CRF1 and CRF2 with equal affinity, and Ucn2 and Ucn3 both preferentially bind CRF2 
[118]. The lower-affinity GR is richly expressed throughout the hippocampus and the prefrontal 
cortex, limbic structures that are implicated in the feedback regulation of the HPA axis [119, 
120]. Through electrical and chemical stimulation, genetic manipulation, and lesion studies, 
these brain regions have been shown to be responsible for negative feedback inhibition of the 
stress response through GR binding, likely in parallel due to innervation of common subcortical 
targets [120, 121]. The high-affinity MR can be bound at low circulating levels of glucocorticoids, 
and is thus thought to be important in ambient glucocorticoid signaling [122].  
These receptors are also prevalent within brain regions associated with affective, stress, 
and nociceptive circuitries. Studies have described central activation of CRF receptors 
mediating stress-related changes in GI function [123, 124]. Additionally, studies in children 
exposed to severe deprivation, neglect, or abuse report lower baseline levels of glucocorticoids 
[112, 125]. It has been hypothesized that this may be due to a downregulation of the HPA axis 
at the level of the pituitary in response to chronic drive of CRF from the hypothalamus [126], or 
target tissue hypersensitivity to glucocorticoids [127]. Limbic structures, including the frontal  
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Figure 1.1  A schematic diagram of the HPA axis. When a stress perceived, neurons in the 
paraventricular nucleus (PVN) of the hypothalamus secrete corticotropin-releasing factor (CRF) 
and arginine vasopressin (AVP). This triggers the subsequent release of adrenocorticotropic 
hormone (ACTH) from the anterior pituitary, which in turn signals the production of 
glucocorticoids (cortisol in humans, corticosterone in rodents) by the adrenal cortex. CRF can 
also be released in the periphery to act on mast cells and enteric neurons. Glucocorticoids act in 
negative feedback loops at various levels of the system (pituitary, hypothalamus, hippocampus, 
frontal cortex) to trigger the shutdown of the HPA axis and a return to homeostasis through the 
activation of CRF receptors (CRF1 and CRF2) and the glucocorticoid receptors (glucocorticoid 
receptor (GR) and mineralocorticoid receptor (MR)). In the hypothalamus and anterior pituitary, 
CRF and ACTH syntheses are halted, respectively. CRF and ACTH production are also 
arrested in the amygdala and hippocampus, limbic structures that respectively activate and 
inhibit the hypothalamus. 
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cortex, amygdala, and hippocampus, provide descending regulatory input to the HPA axis 
through interneurons that project to the PVN of the hypothalamus. Under normal conditions, the 
amygdala and hippocampus stimulate and inhibit CRF production/secretion from the PVN, 
respectively, working in opposition to one another to control the activation of the HPA axis [128, 
129]. Stress exposure promotes CRF release in the central amygdala, a limbic structure 
involved in memory processing, decision-making, and emotional reactions [130]. Chronic 
glucocorticoid exposure increases expression of CRF mRNA [131, 132], suggesting a stress 
sensitization that may be involved in the development of stress-related pathologies [120].  
Rodent models of have illustrated a potential role of the HPA axis in visceral organ 
sensitivity and function as well. Intrathecal administration of a CRF2 antagonist prior to UBD was 
able to attenuate unpredictable footshock-induced urinary bladder hypersensitivity [133]. 
Treatment with CRF1 antagonist reduced both bladder filling and micturition volumes that were 
initially increased due to intrathecal administration of CRF or Ucn2 [134]. Klausner et al., 
however, observed the opposite effect. CRF administration decreased micturition volume in 
normal Wistar rats, and intrathecal administration of astressin, a non-selective CRF1/CRF2 
antagonist, increased void volumes of high-anxiety Wistar-Kyoto rats [135]. In a recent study 
published from our lab, Pierce et al. showed NMS increased female VMR to vaginal balloon 
distention (VBD), as well as significant increases in IL-10 and NGF mRNA levels in the bladders 
of NMS-exposed female mice [136]. Additional work is underway to further investigate the effect 
of NMS on bladder sensitivity and function. Our lab has also shown NMS to also induce referred 
prostate sensitivity in male mice [137] (the impact of NMS in male mice will be further discussed 
in later chapters). Together, these studies suggest components of the HPA axis to be involved 
in bladder, vaginal, and referred prostatic sensitivity, but the mechanism within these 
genitourinary systems is still unclear. 
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Pelvic pain and urinary symptoms both contribute to the reduced quality of life and 
depressive mood experienced by CP/CPPS patients [100, 138]. Depression and catastrophizing 
(the tendency to employ a set of pain-associated cognitive appraisals referred to as ruminative, 
magnifying, and helpless when undergoing or anticipating pain [100, 139]), can also influence 
the HPA axis. Studies have shown that HPA axis dysregulation may lead to abnormal 
inflammatory responses, resulting in chronic inflammatory and pain conditions such as 
fibromyalgia, IC/PBS, and CP/CPPS [91, 100, 140, 141]. In fact, men with CP/CPPS have a 
greater waking cortisol slope compared to healthy, age-matched controls, suggesting a 
dysfunctional HPA axis [100, 140].  
 
Mast cells 
 Mast cell activation and degranulation has been proposed as a possible underlying 
cause for both CP/CPPS and IC/PBS [93]. Mast cells are multifunctional immune cells that 
express high-affinity immunoglobulin E receptors and release potent inflammatory mediators 
including, but not limited to, leukotrienes, cytokines, serotonin, histamine, and proteases, such 
as tryptase [142]. Involved in the innate immune response, hematopoietic progenitors of mast 
cells develop in the bone marrow and are recruited to the peripheral tissues, primarily 
interfacing with the environment (e.g., the respiratory-, gastrointestinal-, and genitourinary 
tracts), where they take up residence and undergo maturation following a complex network of 
signaling and transcription factors [143, 144]. Mast cells can be activated to degranulate and 
release their stores of immune mediators by chemokines, such as monocyte chemoattractant 
protein 1 (MCP-1) and macrophage inflammatory protein 1α (MIP-1α) [145, 146], as well as 
CRF and Ucn1 [147]. As mast cells are often found in close proximity to nerves and their 
contents are known to act on nociceptive fibers, it is strongly asserted that mast cells play a key 
role in peripheral sensitization in chronic pain.  
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 The role of mast cells as important mediators of chronic pelvic pain has been 
appreciated more widely in recent years. Though studies have reported varied degrees of mast 
cell degranulation and activation, CP/CPPS biopsies were observed having altered granular 
structure [148] and decreased numbers of intact mast cells [149], suggesting mast cell 
activation without complete degranulation and increased rate of complete degranulation could 
occur in CP/CPPS. Biopsies from IC/PBS patients have similarly revealed increased mast cell 
infiltration [150-155] and close proximity to density populated substance P (SP)-
immunoresponsive nerve fibers [156]. Concentrations of tryptase and carboxypeptidase A 
(CPA3), a marker of mast cell activation, have been found to be increased in urine samples 
from CP/CPPS patients [157]. Mast cell tryptase and nerve growth factor (NGF) levels have also 
been shown to be increased in expressed prostatic secretions from patients [43]. Mast cell 
tryptase has been demonstrated to be elevated in IC/PBS urines [158, 159].  Mast cell tryptase 
is a component of mast cell granules and is released during degranulation.  Furthermore, 
elevated NGF levels in seminal plasma have been demonstrated to be directly correlated with 
pain severity [160, 161]. Elevated concentrations of NGF, histamine, and proinflammatory 
cytokines have been observed in IC/PBS patients’ serum [162] and urine [74, 163-165].  
 Mast cells have been found in rat models of autoimmune (EAP) [54] and spontaneous 
prostatitis [166], as well as in a mouse model of NMS-induced visceral hypersensitivity studied 
in our lab [137]. EAP studies have reported increases in mast cell infiltration, activation, and 
degranulation after induction [43, 157, 167] ; moreover, the appearance of intact mast cells 
decreased with study progression [43] similar to increases of complete degranulation observed 
in CP/CPPS biopsies [149]. Other EAP model studies have reported increases in NGF 
expression, which has been known to enhance neuronal excitability and density in peripheral 
tissues [57, 166] Furthermore, mast cell-deficient KitW-sh/KitW-sh mice failed to develop pelvic 
mechanic allodynia 5 days following EAP induction, unlike wild type controls; and treatment with 
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the mast cell stabilizer disodium cromoglycate (cromolyn) or histamine receptor antagonists 
attenuated pain behaviors in EAP mice [43]. These studies strengthen association between 
mast cells and the development of CP/CPPS.  
Neonatal maternal separation 
Rodent models incorporating early life stress have demonstrated altered anxiety-like 
behaviors, increased colorectal sensitivity, and modified bowel function associated with 
disrupted functioning of the HPA axis. Neonatal maternal separation (NMS) in rodents has been 
used for several decades as a model of early life stress that significantly impacts the functioning 
of the HPA axis [168-171]. In rats, the neonatal period between postnatal day 1 (P1) through 
P14 is critical for neurological development. In humans, this period begins prenatally and lasts 
until age 5 [172]; the nervous system is exceptionally pliant to nurturing and adverse events 
during this critical window of development [173]. Maternal deprivation in rats lowered GR 
expression in the hippocampus and cortex, resulting in protracted responses to acute stress and 
deficient glucocorticoid feedback in rats [174]. Altered hypothalamic and limbic CRF receptor 
and GR expression has also been reported [174-177].  These animals also had increased 
corticosterone levels [178] and prolonged ACTH release following stressful events [171, 174, 
175, 177]; induced depressive behaviors including heightened anxiety behaviors in an open field 
area [113, 168-170]; and increased visceromotor response (VMR) to colorectal distention [113, 
179-181]. The hyperalgesia was exacerbated following exposure to water avoidance stress and 
was prevented by a preemptive administration of a selective CRF1 antagonist [182], indicating 
that CRF may play a critical role in the development of visceral hypersensitivity. Altered 
functioning of the HPA axis likely drove the heightened sensitivity to acute stressors and 
anxiety-provoking situations in NMS rats [176, 183], as CRF mRNA and CRF1 immunoreactivity 
were both elevated following NMS in PVN, amygdala, and locus coeruleus (LC) [177]. 
Moreover, NMS rats displayed significantly higher levels of c-Fos expression in the cingulate 
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cortex and superficial and deeper laminae of the spinal cord in response to colorectal distention 
than did naïve rats [184, 185], suggesting that early life stress likely induced functional changes 
in the central descending modulatory system that may have contributed to hyperalgesia [2]. 
Chronic stress compromises the hippocampal inhibition of the HPA axis through 
diminished receptor expression or ligand resistance, as in the case of GR [186], thereby 
reducing descending inhibition onto the PVN and in turn increasing CRF release and 
glucocorticoid production [128, 129]. NMS has been shown to alter expression of hippocampal 
CRF and glucocorticoid receptors, thus affecting limbic feedback. Hippocampal CRF1 and CRF2 
were both found to be increased in NMS rats, both prior to and following acute stress exposure 
[176], whereas GR expression was significantly decreased [174, 175].  
Exercise 
Voluntary physical activity can favorably influence brain plasticity by facilitating 
neurogenerative, neuroadaptive, and neuroprotective processes [187]. Chronic voluntary 
physical activity also attenuates neural responses to stress in brain circuits responsible for 
regulating peripheral sympathetic activity; mitigating several harmful consequences of acute 
stress exposure [187]. In rodents, exercise has been shown to attenuate both anxiety- and 
depression-related behaviors in NMS rats by normalizing gene expression changes within limbic 
structures regulating HPA axis output [188, 189]. Chronic wheel running in rats prevents 
behavioral consequences of uncontrollable stress, including features of depression and anxiety 
[187, 190-192]. Free access to running wheels also normalized hippocampal GR and BDNF 
mRNA levels in NMS rats [188]. In a separate study, exercised NMS rats exhibited a significant 
decrease in depressive behavior compared to sedentary counterparts [189]. Clinically, exercise 
has been shown to reduce the effects of depression and anxiety, as well as decrease 
associated perceptions of pain [193, 194]. Exercise has also been shown to significantly 
improve symptom severity in patients with IBS [193, 195-199], fibromyalgia [200-202], and 
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depression and/or anxiety [203-205]. To our knowledge, exercise has not been investigated as 
a potential therapeutic intervention for NMS-induced visceral hypersensitivity.  
Study significance 
Experiencing adverse childhood events can permanently alter the functioning of the HPA 
axis, serving as a risk factor for developing functional pain disorders [101, 102, 206-212]. This is 
particularly worrisome in the U.S., as the child maltreatment rate has consistently risen over the 
past decade [213] and the birthrate is steadily rising only for women over the age of 40 [214-
217]. Babies born to women of this age group are significantly more likely to be admitted to the 
neonatal intensive care unit (NICU) where they are exposed to numerous stressors, including 
periods of prolonged maternal separation [218]. At birth, a human child’s glucocorticoid levels 
increase sharply in response to various stressors, such as physical exams and heel lances 
experienced by infants in the NICU, during a period when the HPA system is extremely labile 
[112].  Further understanding of the development and maintenance of chronic pelvic pain will 
better inform appropriate assessment and interventions, thus leading to improved physical and 
psychological function. 
Due to the shared symptomology and comorbidity of functional pelvic pain disorders, it 
would be most advantageous to develop a reliable animal model depicting multiple conditions. 
This project repurposed a well-validated NMS model that results in colonic sensitivity indicative 
of altered HPA function [178, 179, 181, 184, 185]. Recent work from our laboratory has shown 
that NMS generates comorbid urogenital pain and anxiety behaviors in female mice [136]; and, 
in male mice of the same strain (C57BL/6), increases susceptibility to experimental colitis [219], 
induces referred prostate hypersensitivity, and increases mast cell degranulation in urogenital 
tissues [137]. We applied this model in male mice to more accurately replicate CP/CPPS and 
common comorbid disorders, particularly IC/PBS, depression, and anxiety.  
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Exercise has been shown to improve health outcomes for a multitude of diseases and 
has a beneficial impact on depression, with animal behavioral models corroborating [187]. 
Voluntary exercise has been shown to attenuate molecular and behavioral changes associated 
with a dysfunctional HPA axis and significantly improves symptom severity in patients with IBS 
[193, 195-199], fibromyalgia [200-202], and depression and/or anxiety [203-205]. Rodent 
studies have shown that voluntary exercise can normalize abnormal hippocampal gene 
expression resulting from NMS, thereby reinstating proper descending limbic control of the HPA 
axis [188]. To our knowledge, exercise has not been investigated as a potential therapeutic 
intervention for NMS-induced visceral hypersensitivity. 
The objective of this project was to investigate if acute adult stress would exacerbate the 
effect of early life stress on comorbid chronic pelvic pain syndromes and psychological 
disturbances in male mice, to gain novel insight into the mechanisms underlying these comorbid 
disorders, and to understand whether voluntary exercise could prevent or reverse those effects. 
We intended to identify key modulators that could serve as potential pharmacological targets, as 
well as provide the first pre-clinical evidence on the efficacy of an exercised-based therapeutic 
intervention, an easily translatable and inexpensive intervention. This work will present the first 
evidence of the impact of exercise on the effects of NMS, providing preclinical evidence for a 
treatment option for patients. The central hypothesis of this project was that acute adult stress 
would intensify, while exercise would attenuate neonatal maternal separation (NMS)-induced 
long-term anxiety and dysfunction/hypersensitivity of the pelvic organs by restoring proper 
functioning of the HPA axis. We found that NMS exposure induced mechanical perigenital 
allodynia, increased susceptibility to experimental colitis, altered micturition patterns, increased 
mast cell degranulation, and decreased HPA axis output. NMS did not, however, result in 
anxiety-like nor depression-like behaviors. Water avoidance stress did significantly impact some 
of these measures, but did not enhance the effect of NMS. Lastly, we did see improvement of 
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perigenital sensitivity following both early and late exercise interventions, but did see more 
robust improvements in behavioral measurements after early exercise than late exercise. Late 
exercise, however, made a greater impact on central gene expression changes in limbic 
structures involved in HPA axis activity. Here, I have provided novel insight into the mechanisms 
potentially underlying significantly debilitating chronic pelvic pain disorders following early life 
stress. I also present evidence on the efficacy of therapeutic exercise, an easily translatable 
intervention, as a potential treatment strategy for these comorbid disorders. This work will 
present the first evidence of the impact of exercise on the effects of NMS, providing preclinical 
evidence for a treatment option for patients. Positive results from this study could potentially be 
applied to other functional pain disorders linked to early life stress, including fibromyalgia and 
migraine, thus broadening the impact of our findings. The benefits/impact of the work would be 
improving the quality of life of individuals suffering from these debilitating mood and pain 
disorders, as well as decreasing the overall annual expense of treatment for these comorbid 
disorders. 
Clinical implications: Chronic pelvic pain disorders are not well understood in their 
pathology and are often co-diagnosed with other pain and/or mood disorders; thus, complicating 
treatment options. Here, I have provided novel insight into the mechanisms potentially 
underlying these debilitating disorders following early life stress. I also present evidence on the 
efficacy of therapeutic exercise, an easily translatable intervention, as a potential treatment 
strategy for these comorbid disorders. 
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Chapter II: Methods 
 This project involved two main arms: 1) to determine the impact of neonatal maternal 
separation and adult stress on male mice; and 2) to evaluate the therapeutic potential of an 
early-in-life or late-in-life voluntary exercise intervention. 
Animals 
 All experiments were performed using male C57Bl/6 (Charles River, Wilmington, MA) 
born and housed in the Research Support Facility at the University of Kansas Medical Center. 
Mice were housed on a 12-hour light cycle from 600 to 1800 hours and received water and food 
ad libitum. All research performed conformed to the National Institute of Health Guide for the 
Care and Use of Laboratory Animals in accordance to the guidelines specified by the University 
of Kansas Medical Center Animal Care and Use Protocols. 
Neonatal maternal separation 
 Pups were removed as whole litters from the home cage for 180 minutes (1100-1400 
hours) daily from postnatal day 1 (P1) to P21, date of birth being P0. Litters were placed into 
clean glass beakers with bedding and enrichment from the home cage and held in an incubator 
at 33C and 50% humidity for 21 consecutive days [137]. Naïve pups were unhandled outside of 
normal husbandry procedures. Naïve and mice that underwent neonatal maternal separation, 
termed NMS, were weaned on P22.   
Trinitrobenzene sulfonic acid (TNBS) treatment 
Naïve and NMS animals were anesthetized with inhaled isoflurane (4% induction, 2% 
maintenance) and secured on a platform that elevated the pelvic region approximately 5 cm 
above the working surface. A water-based lubricant (KY Jelly, Johnson & Johnson, New 
Brunswick, NJ) was liberally applied to the perianal region to avoid sensitization of surrounding 
somatic tissues. Mice received an intracolonic instillation of TNBS (0.1 mL of 50 mg/mL or 20 
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mg/mL in 50% EtOH) or saline (0.1 mL) using an oral feeding needle attached to a 50 L 
Hamilton syringe. Mice remained in an elevated position for 5 minutes to prevent leakage. Mice 
were then allowed to recover from anesthesia and were returned to their home cages. 
Water avoidance stress 
 Mice were exposed to water avoidance stress (WAS) for 1 hour of 1 day or 7 
consecutive days within the first 6 hours of the light cycle. Individual mice were placed on round 
platforms (5 cm diameter) centrally affixed to the bottom of containers (36 cm length x 31 cm 
width x 27 cm depth) filled with room temperature tap water up to 1 cm below the top of the 
platform. 
Electromyographic electrode implantation and colorectal distention 
 Electrode implantation was performed as previously described [220] to measure the 
visceromotor response (VMR) of naïve and NMS mice to colorectal balloon distention (CRD). 
Under inhaled isoflurane (4% induction, 2.5% maintenance) and aseptic conditions, the bare 
ends of two Teflon-coated stainless steel wires (3 mm; Grass Technologies, West Warwick, RI) 
were inserted into the right lateral abdominal musculature, secured via 5-0 prolene sutures, 
tunneled subcutaneously to a small incision made in the nape of the neck, and externalized for 
access during testing. Skin incisions were closed using 5-0 silk suture. Following recovery from 
anesthesia, mice were housed singly and allowed to recover for a minimum of 4 days before 
undergoing testing.  
 To facilitate balloon insertion and obtain proper restraint during CRD, mice were briefly 
sedated with inhaled isoflurane (4% induction, 2.5% maintenance) and a custom-made, 
catheterized polyethylene plastic balloon (1.5 cm length x 0.8 cm diameter) was inserted into 
the anus until the proximal end of the balloon was 0.5 cm from the anal verge (total balloon 
insertion, 2 cm) and secured the base of the tail with tape. The mouse was then placed into a 
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Broome-style rodent restraint (Kent Scientific, Torrington, CT), the free ends of the electrode 
wires were attached to a differential amplifier (Model 1700, A-M Systems, Sequim, WA), and the 
mice were allowed to recover from anesthesia for 30 minutes. The balloon was inflated with air 
from a compressed nitrogen tank equipped with a dual-stage low delivery pressure regulator 
(Matheson-Linweld, Kansas City, MO) and a separate pressure monitor (World Precision 
Instruments, Sarasota, FL) was used to manually regulate the pressure inside of the balloon. 
Each pressure (15, 30, 45, 60, and 75 mmHg) was applied three times for 20 seconds with a 4-
min rest period in between. A custom-made distension control device (The University of Iowa 
Medical Instruments, Iowa City, IA) was used to control the gas flow through the system. 
Electromyographic (EMG) activity as amplified, filtered, and recorded on a personal computer 
with Spike 2 software (Cambridge Electronic Design, Cambridge, UK) for off-line analysis. The 
VMR was quantified by measuring the area under the curve for the entire distension period 
divided by the duration of the distension and expressed as a percent of baseline activity (10 
seconds prior to CRD). 
Voluntary wheel running 
Exercised mice were housed in cages equipped with stainless steel running wheels (Mini 
Mitter; Bend, OK; or STARR Life Sciences Corp. Oakmont, PA). Quantification of wheel 
revolutions was monitored by Vital View Acquisition and Analysis Software (Harvard Apparatus, 
Holliston, MA) or STARR Life Sciences Vital View Activity Software version 1.1. Average 
running distance per week per animal or per pair was calculated using Microsoft Excel. 
Bladder catheter implantation surgery for cystometry 
 Small rodent bladder catheter implantation was performed as previously described by 
Uvin et al. 2012 [221]. Under anesthesia of inhaled isoflurane (4%, 2% maintenance) and 
aseptic technique, a purse-string suture was placed in the dome of the bladder using a 
polypropylene 6-0 monofilament suture. A small cystostomy was performed using an 18 G 
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needle inside the purse string and a PE 50 polyethylene catheter with a small cuff at the end 
(sterilized and flushed with saline prior to implantation) was inserted through the hole. The 
purse-string was tightened and secured around the tube with a surgeon’s knot. The catheter 
was checked for leaks then tunneled subcutaneously to a small incision made in the nape of the 
neck, and externalized for access during testing. The abdominal muscles were closed using 
polypropylene 6-0 monofilament sutures, leaving a passage for the catheter, and the skin 
incisions were closed using silk 5-0 sutures. Mice were immediately treated with 0.3 mg/kg 
buprenorphine, as well as twice daily for two days following surgery. Mice were singly housed 
and allowed to recover for 7 days before undergoing testing. 
Cystometry testing 
 Testing was performed as previously described [221]. After 1 week of recovery from 
bladder catheter implantation surgery, mice were singly restrained within the Small Animal 
Cystometry Lab Station (Catamount Research and Development Inc., St. Albans, VT). The 
externalized catheter was connected to an infusion pump and pressure transducer. The animal 
was undisturbed for an acclimation period of 10 minutes, followed by a 20-minute acclimation 
period during which the bladder was infused with room temperature, sterile saline at a constant 
rate of 20 µL per minute. Infusion continued during a 30-minute testing period or until two 
discrete voiding events were observed. Voiding frequency and intervals, detrusor contraction 
frequency and amplitude, and intravesical pressure were displayed and recorded continuously 
using Cystometry Analysis Software (Catamount).  
Behavioral analysis 
 All mice underwent a 30-minute acclimatization period within the testing room either the 
day of or one day prior to each behavioral test. For both thermal and mechanical hind paw 
sensitivity and mechanical perigenital sensitivity testing, the mice were acclimated to the 
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apparatus for 30 minutes prior to testing and the experimenter was blinded to the group status 
of the mice. 
Open field testing 
Activity in naïve and NMS mice was measured using a Force Plate Actimeter (BASi, San 
Diego, CA), which consists of a rigid, low-mass horizontal plate (44 cm x 44 cm) coupled to high 
sensitivity force transducers on each corner. A Plexiglass enclosure rests a few millimeters 
above the plate to create a transparent enclosure, all of which rests within a light and sound-
attenuated box. Animals were individually placed into the middle of the testing area and allowed 
to move freely for 10 minutes. During this time, the software recorded the distance traveled and 
position of the mouse. The total distance traveled and percent of time spent in the perimeter 
(outermost 8.25 cm; increased time spent in the perimeter is indicative of anxiety [222]) was 
calculated and binned and the data from the second 5 minute bin is reported here. 
Thermal analgesiometer testing 
Naïve and NMS mice were placed in individual clear plastic chambers (11 x 5 x 3.5 cm) 
on the 30°C heated glass surface of a thermal analgesiometer (UARDG; Department of 
Anesthesiology, University of California San Diego, La Jolla, CA). A high intensity light (4.25 
Amperes) was directed at the plantar surface of the hind paw and the latency to withdrawal from 
the stimulus was automatically recorded within 0.01 second. Alternating hind paws were tested 
for a total of three times per side with a minimum of 5 minutes between applications. The 
stimulus terminated automatically at 20 seconds to avoid tissue damage. Individual responses 
were averaged and group means were determined as previously described [223]. 
Mechanical sensitivity monofilament testing 
 Hind paw and perigenital sensitivity were assessed as previously described, [219] and 
[137] respectively. Mice were first acclimated to the sound proof testing room for 30 minutes 
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prior to testing. Naïve and NMS mice were placed into individual clear plastic chambers (11 x 5 
x 3.5 cm) on a wire mesh screen elevated 55 cm above a table. The up-down method was 
performed to test mechanical sensitivity using a standard set of Semmes-Weinstein 
monofilaments (1.65, 2.36, 2.83, 3.22, 3.61, 4.08, 4.31, 4.74 g; Stoelting, Wood Dale, IL) [224, 
225]. Beginning with the 3.22 g monofilament, mice received a single application to either the 
plantar surface of the right hind paw or scrotum. A negative response was followed by the next 
larger filament and a positive response (considered a brisk jerk or jump or licking the affected 
area) was followed by the next smaller filament. The experimenter continued to move up or 
down the series, depending on the previously elicited response, for an additional four 
applications after the first positive response was observed for a minimum of five or a maximum 
of nine total monofilament applications. The value in log units of the final monofilament applied 
in the trial series was used to calculate 50% g threshold for each mouse and group means were 
determined as previously described [224]. 
Sucrose preference testing 
 Two liquid preference paradigms were employed. When investigating the impact of NMS 
and/or WAS exposure on sucrose preference, mice were individually housed in and acclimated 
to BioDAQ Liquid Choice Unplugged Allentown cages (Biological Data Acquisition, New 
Brunswick, NJ) equipped with two Polysulfone BioDAQ drinking bottles. Over a 48-hour 
acclimation period, both bottles were with standard drinking water. Following this period, one 
bottle was replaced with 1% sucrose diluted in drinking water. Fluid volumes were recorded 
every 24 hours for 4 days to assess baseline sucrose preference prior to WAS exposure. After 1 
hour WAS exposure, mice were returned to two-choice liquid preference cages and liquid 
consumption was recorded every 24 hours until 8d post-WAS. Additionally, from the beginning 
from the acclimation period to the end of the 8d post-WAS, positions of the bottles were 
swapped to control for possible side preference. 
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When investigating the impact of NMS and/or exercise on sucrose preference, mice were 
individually housed in and acclimated to the liquid choice cages for 24 hours. Following the 
acclimatization period, one bottle was filled with 1% sucrose solution. Fluid volume levels were 
recorded at the beginning and the end of a 24-hour testing period. For both paradigms, the total 
volume and percentage of 1% sucrose was calculated. 
Elevated plus-maze testing 
 Anxiety-like behaviors were measured in mice as previously described by Walf and Frye 
[226]. Mice were placed in the center of an elevated (60 cm above the floor) plus-maze 
consisting of two open and two closed arms opposite each other in a plus-shaped formation. 
Testing conditions were kept as consistent as possible. All mice were tested within the first 
seven hours of the light cycle and placed into the center of the maze facing the same open arm. 
Mice were allowed to freely explore the maze for a testing period of 5 minutes while a digital 
camera captured the activity from above. The number of entries into and the time spent in open 
and closed arms were recorded at the time of testing in the event a video recording was 
unusable. Blinded scorers reviewed the recorded test sessions and were able to record the 
number of entries and time spent in each arm more accurately. 
Micturition analysis 
 Surfaces were cleaned with 70% ethanol and wiped dry. Naïve and NMS mice were 
acclimated to the testing room in their home cages to the testing room for 30 minutes prior to 
micturition pattern data collection. Mice were singly confined to a sheet of filter paper (11 x 5 x 
3.5 cm) for 1 hour using an inverted Micro-Isolator cage bottom (Lab Products, Seaford, DE). At 
the end of the testing period, the filter paper was left to dry while mice were returned to home 
cages and the animal facility. Once the filter papers were dry, fecal pellets were counted (data 
not shown) and urine spots were visualized using UV light. The total area (cm2) and number of 
urine spots were recorded. 
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In vitro assays 
Myeloperoxidase assay 
Mice were overdosed with inhaled isoflurane (>5%) and the distal 1.5 cm of colon was 
dissected and the fecal matter, excess blood vessels, and mesentery were removed. The tissue 
was weighed, added to a beaker containing 1 ml 0.5% hexadecyltrumethylammonium bromide 
(HTAB; Sigma), and finely minced using spring scissors. The solution was transferred to a 15 ml 
centrifuge tube, along with another 2 ml HTAB, and sonicated for 10 s before being 
homogenized for 30 s. Another 2 ml HTAB was added and the tube was placed on dry ice until 
all samples were similarly processed. The samples underwent three freeze-thaw cycles, were 
centrifuged twice, and loaded in triplicate, along with MPO standards (Calbiochem, San Diego, 
CA), onto a 96-well plate. The standards and samples were reacted with O-dianisidine 
dihydrochloride (Sigma) and read on a plate reader at 460 nm every 20 s for 15 min. The slope 
for each standard reading was calculated and plotted and the slope of those values was used to 
calculate the units of MPO activity/tissue weight for each sample. 
Acidified toluidine blue mast cell staining 
 Mast cells were stained and quantified as previously described [137]. Mice were 
overdosed with inhaled isoflurane (>5%) and intracardially perfused with ice cold 4% 
paraformaldehyde. Urinary bladders and prostates were removed, post-fixed in 
paraformaldehyde at room temperature for 1 hour, cryoprotected in 30% sucrose in 1x PBS at 
4°C overnight, and frozen in a heptane bath on dry ice. Tissue was transversely cut into 10 µm-
thick (bladder) and 7 µm-thick (prostate) cryosections using a cryostat held at -22°C. 
Cryosections were then stained with acidified toluidine blue to visualize mast cells. The 
percentage of degranulated/total mast cells was calculated in 8 separate, non-serial sections 
spanning the length of each tissue. 
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mRNA extraction and qRT-PCR 
 Mice were overdosed with inhaled isoflurane (>5%). The 1.5 cm distal segment of the 
colon was removed, bisected longitudinally (to facilitate both mRNA and protein [see below] 
analysis), snap frozen in liquid nitrogen, and stored at -80C. Total RNA was isolated using 
Trizol reagent (Ambion, Austin, TX) and RNeasy Mini Kit (Qiagen, Valencia, CA). The 
concentration and purity were determined using a 2100 Bioanalyzer (Agilent Technologies, 
Santa Clara, CA) and cDNA was synthesized from total RNA (0.63 μg) using the iScript cDNA 
Synthesis Kit (Bio-Rad, Hercules, CA). Quantitative RT-PCR was performed using 
SsoAdvanced SYBR Green Supermix (Bio-Rad) and a Bio-Rad iCycler IQ real time PCR 
system with indicated 20µM primers (Integrated DNA Technologies, Coralville, IA) listed in 
Table 2.1.  GAPDH was used as a housekeeping gene for brain tissues and β-actin was used 
as a housekeeping gene for bladder and prostate. 
Samples were run in triplicate and negative control reactions were run with each 
amplification series. To reduce variability among efficiency due to fluctuations in baseline 
fluorescence, the raw (i.e. non-baseline corrected) PCR data was imported to the LinRegPCR 
software (version 2012.3) [227-229] and PCR efficiency values were derived for each individual 
sample by fitting a regression line to a subset of data points within the sample’s log-linear 
phase. Threshold cycle (Ct) values were subtracted from that of the selected housekeeping 




Table 2.1 Primers used for real-time PCR analysis 
Gene Forward (5’ – 3’) Reverse (3’ – 5’) 
IL-6 CTGCCAGAGACTTCCATCCAGTT GAAGTAGGGAAGGCCGTGG 
IL-10 GCTGGACAACATACTGCTAACC ATTTCCGATAAGGCTTGGCAA 
Artemin GGCCAACCCTAGCTGTTCT TGGGTCCAGGGAAGCTT 
SCF CCCTGAAGACTCGGGCCTA CAATTACAAGCGAAATGAGAGCC 
MCP-1 AGGTCCCTATGGTGCCAATGT CGGCAGGATTTTGAGGTCCA 
NGF ACACTCTGATCACTGCGTTTTTG CCTTCTGGGACATTGCTATCTGT 
CRF CCTCAGCCGGTTCTGATCC GCGGAGGAAGTATTCTTCACCC 
Ucn2 ACCCGTGTCATACTCTCCCTG CAGCCTTGTAACGAGCCTG 
CRF1 CCCTGCCTTTTTCTACGGTGT TTCCCGGTAGCCATTGTTTGT 
CRF2 CCTGTGGACACTTTTGGAGCA TGTTGCAGTAGGTGTAGGGAC 
GR GACTCCAAAGAATCCTTAGCTCC CTCCACCCCTCAGGGTTTTAT 
MR GAAAGGCGCTGGAGTCAAGT CCATGTAGCTGTTCTCATTGGT 
BDNF CAGGTTCGAGAGGTCTGACGA CGCGTCCTTATGGTTTTCTTCG 
-actin AGTGTGACGTTGACATCCGTA GCCAGAGCAGTAATCTCCTTCT 





 Total protein was isolated from approximately 50 mg of snap-frozen colon, bladder, and 
prostate tissue using Cell Extraction Buffer (Invitrogen, Grand Island, NY) containing Halt 
protease and phosphatase inhibitors (ThermoFisher Scientific, Waltham, MA) and Na3VO4 
(Sigma, St. Louis, MO). Protein concentrations were determined using a DC protein assay 
(ThermoFisher). Samples were reduced by heating to 95°C for 5 minutes in the presence of 2-
mercaptoethanol, subjected to SDS-PAGE (Criterion 4 – 12% Bis-Tris gels; Bio-Rad, Hercules, 
CA), and transferred to Nitrocellulose transfer membrane (Whatman GmbH, Dassel, Germany) 
by Criterion Blotter wet transfer (Bio-Rad). The membranes were blocked for 1 hour at room 
temperature in 5% milk in Tris-buffered saline with Tween-20 (TBST) and incubated overnight at 
4°C with antisera to CRF1, CRF2, and GAPDH diluted in 5% milk in TBST. Membranes were 
then washed with TBST and incubated for 1 hour with anti-rabbit secondary. Dilution ratios of 
primary antibodies are reported in Table 2.2. Densitometry was performed using Quantity One 
4.6.9 software (Bio-Rad). 
Table 2.2 Antibodies and dilution ratios used for Western blot analysis 





CRF1 (Millipore, Billerica, MA) 1:250 1:500 1:333 
CRF2 (Millipore) 1:1000 1:800 1:1000 
GAPDH  
(Cell Signaling Technology, Danvers, MA) 
1:2000 1:2000 1:2000 




Serum corticosterone ELISA  
 Trunk blood was collected at the time of sacrifice during the early half of the light-cycle 
(0800-1100 hours), allowed to clot for 1 hour on ice, and centrifuged at 10,000 rpm for 10 
minutes. Serum (clear supernatant) was collected and stored at -20°C until analysis. Serum 
corticosterone (CORT) was quantified using ELISA kit according to manufacturer’s instructions 
(ALPCO, Salem, NH). 
Statistics 
Calculations were made using Microsoft Excel and statistical analysis was performed 
using Student’s t-test or two-way (with or without repeated measures) analysis of variance 
(ANOVA) followed by Bonferroni’s or Fisher’s LSD posttests, and correlations were analyzed 
using Pearson’s correlation (IBM SPSS Statistics, IBM Corporation, Armonk, NY; GraphPad 
Prism 6, GraphPad Software, La Jolla, CA), as denoted in the manuscript.  All data are 







Chapter III: Results: Characterizing NMS in male mice (colon) 
Experimental design 
Naïve mice and mice subjected to neonatal maternal separation (NMS) from postnatal 
day 1 (P1) though either P14 or P21 were assessed as adults for open field behavior, hind paw 
sensitivity, and visceromotor response (VMR) to colorectal distension (CRD). VMR was also 
measured before and after treatment with intracolonic trinitrobenzene sulfonic acid (TNBS; 2 mg 
or 5 mg) or exposure to acute (1 day) or chronic (7 days) water avoidance stress (WAS). 
Myeloperoxidase (MPO) activity, proinflammatory gene and corticotropin-releasing factor (CRF) 
receptor expression were measured in distal colon. Table 3.1 describes the ages of the mice at 
experimental time points. 
NMS increased hind paw sensitivity, but not baseline colorectal sensitivity or anxiety 
measures 
 Male mice underwent NMS or remained unhandled (naïve) for the first 21 days of life 
and were assessed as adults for susceptibility to colorectal inflammation and acute or chronic 
exposure to WAS (Table 3.1). At baseline, naïve and NMS mice were not remarkably different in 
regards to colorectal sensitivity, measured as the VMR during CRD (Figure 3.1A). Open field 
exploratory behavior and hind paw mechanical and thermal sensitivity were also measured in 
naïve and NMS mice at baseline and following CRD. The percent of time spent in the perimeter 
of the open field was not significantly different between naïve and NMS mice at baseline; 
however, exposure to CRD significantly increased overall time spent in the perimeter, 
specifically in NMS mice (Figure 3.1B). The withdrawal threshold to application of Semmes-
Weinstein monofilaments to the plantar surface of the hind paw was significantly reduced in 
NMS mice, particularly post-CRD (Figure 3.1C). Thermal withdrawal latency to a radiant heat 
source on the plantar surface of the hind paw was significantly shorter in NMS mice at baseline, 
but not following CRD (Figure 3.1D).  
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Table 3.1 Age of mice at experimental time points 




No insult (n=10) 13   
Saline (n=6) 8 9 10 
TNBS 2 mg (n=6) 10 11 12 
TNBS 5 mg (n=6) 8 9 10 
1d WAS (n=6) 10 10 11 
7d WAS (n=6) 10 10-11 12 
Open Field 
CRD (n=8) 6 13 17 
Hind paw Sensitivity 
CRD (n=8) 7 13 19 
Naïve and NMS mice underwent behavioral or physiological testing at the above noted ages (in 
weeks) prior to and/or following introduction of an insult, including colorectal distension (CRD), 
intracolonic trinitrobenzene sulfonic acid (TNBS), or acute (1d) or chronic (7d) exposure to water 
avoidance stress (WAS). Repeated tests were performed on the same mice for all CRD 
experiments involving post-insult measurements. Open field and hind paw sensitivity tests were 
performed on separate groups of mice either at baseline or following CRD. 
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Figure 3.1 Colorectal, mechanical, and thermal sensitivity and behavior after colorectal 
distension.  The visceromotor response (VMR) during colorectal distension (CRD) was 
measured, as well as open field activity and mechanical and thermal hind paw sensitivity prior to 
and following CRD, in male mice that did and did not (naïve) undergo neonatal maternal 
separation (NMS). A) No difference in VMR, measured as the electromyographic (EMG) activity 
of the abdominal muscles during CRD, was observed between naïve and NMS mice. B) At 
baseline, naïve and NMS mice spent a similar percent of time in the perimeter of an open field; 
however, following exposure to CRD, there was an overall significant increase in the percent of 
time spent in the perimeter, specifically in NMS mice. C) Mechanical hind paw withdrawal 
thresholds were significantly reduced in NMS mice across both measurements, particularly 
post-CRD. D) Thermal hind paw withdrawal latencies were significantly shorter in NMS mice at 
baseline, compared to naïve, but not post-CRD. An overall effect of NMS and an NMS/CRD 
interaction was observed across both measurements. Brackets indicate a significant effect of 
NMS (*, **p < 0.05, 0.01), CRD (##p < 0.01), or an NMS/CRD interaction (+p < 0.05) two-way 
RM ANOVA; *, **p < 0.05, 0.01 vs. naïve, #p < 0.05 vs. BL, Bonferroni posttest. 
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NMS increased susceptibility to TNBS 
To determine whether NMS increased susceptibility to experimental colitis, two different 
concentrations of TNBS were applied intracolonically. Application of 2mg/mouse TNBS did not 
significantly alter body weight, survival, or colorectal sensitivity of naïve or NMS mice, compared 
to saline-treated counterparts, over the 4 days immediately following treatment (Figure 3.2). 
However, 5mg/mouse TNBS resulted in significant weight loss in NMS mice, compared to both 
5mg TNBS-treated naïve mice and saline-treated NMS mice (Figure 3.2B) and also decreased 
survival rate in NMS mice, compared to 5mg TNBS-treated naïve mice (16.7%  15.2 vs. 100%; 
p = 0.0006, Log-rank Mantel-Cox test). Neutrophil activation was measured by MPO activity and 
NMS mice that were separated for only the first 14 days of life and treated with 5mg TNBS had 
significantly higher MPO at 4 d post-treatment compared to baseline NMS measurements 
(Table 3.2). NMS had a significant impact on colorectal sensitivity in both the saline-treated and 
5mg TNBS-treated groups; however, TNBS treatment showed no significant impact on 
colorectal sensitivity in either NMS or naïve mice (Figure 3.2A). 
NMS enhanced acute WAS-induced colorectal hypersensitivity 
Colorectal sensitivity was measured prior to and 1 d after either a single exposure to 1 h 
of WAS (1d WAS) or 7 consecutive daily exposures to 1 h of WAS (7d WAS) to determine 
susceptibility to acute or chronic stress, respectively. The VMR during the entire CRD series 
was significantly higher in NMS mice exposed to 1d WAS compared to their baseline 
measurements (Figure 3.3A). In particular, the VMR at 60 and 75 mmHg was significantly 
higher in NMS mice after 1d WAS than both their baseline measurements and that of their naïve 
counterparts (Figure 3.3A). Exposure to 1d WAS did not significantly impact the VMR of naïve 
mice (Figure 3.3A). Exposure to 7d WAS did not significantly impact the VMR of either naïve or 
NMS mice (Figure 3.3B). 
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Figure 3.2 Colonic sensitivity and body weight after TNBS treatments.   Mice that underwent 
neonatal maternal separation (NMS) were dose-dependently susceptible to intracolonic 
administration of trinitrobenzene sulfonic acid (TNBS). Mice were assessed for colorectal 
sensitivity and weighed to determine baseline (BL) measurements and then treated with saline, 
2 mg TNBS, or 5 mg TNBS. Body weight was measured daily and colorectal distension (CRD) 
was performed on day 4 post-TNBS. A) The total electromyographic (EMG) activity is 
expressed as the area under the curve (AUC) for the entire CRD pressure series. No treatment 
effects were observed for saline, 2 mg TNBS, or 5 mg TNBS; however, NMS significantly 
impacted VMR in the saline-treated and 5 mg TNBS-treated groups. B) NMS mice given 5 mg 
TNBS lost significantly more body weight over three subsequent days than either naïve mice 
treated with 5 mg TNBS or saline-treated NMS mice. Brackets indicate a significant effect of 
NMS (*p < 0.05), two-way RM ANOVA; *, **p < 0.05, 0.01 vs. naïve, #, ##p < 0.05, 0.01 vs. 
saline, Bonferroni posttest. 
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Table 3.2 Myeloperoxidase activity following trinitrobenzene sulfonic acid treatment 
 Naïve NMS‡ 
Baseline (n=3) 0.852 ± 0.20 0.606 ± 0.25 
1d post (n=4) 6.43 ± 1.64 8.06 ± 0.77 
4d post (n=4) 4.75 ± 1.81 12.12 ± 3.81## 
Myeloperoxidase (MPO) activity (expressed as U mg-1 tissue weight) was measured in distal 
colon from naïve and NMS mice prior to (baseline) and following intracolonic instillation of 5 mg 
trinitrobenzene sulfonic acid (TNBS). Treatment with TNBS significantly increased MPO levels 
in both groups (p=0.0071, two-way ANOVA). Naïve MPO levels peaked at 1d post-TNBS, while 
NMS MPO levels continued to increase at 4d post-TNBS. ##p < 0.01 vs. baseline, Bonferroni 
posttest. ‡ denotes NMS (neonatal maternal separation) mice that were separated from 
postnatal day 1-14.  
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Figure 3.3 Visceromotor response to colorectal distension after WAS.   Acute, but not chronic, 
exposure to water avoidance stress (WAS) selectively increased colorectal sensitivity in NMS 
mice. A) The electromyographic (EMG) activity of the abdominal musculature was measured to 
determine the visceromotor response (VMR) to colorectal distension (CRD) both prior to 
(baseline) and 1 day after a single exposure to WAS (1d WAS) in naïve and NMS mice. 
Exposure to 1d WAS significantly increased VMR of NMS mice compared to their baseline 
measurements. This was particularly evident at the highest balloon pressures applied, 60 and 
75 mmHg. B) Chronic daily exposure to WAS (7d WAS) had no impact on VMR during CRD in 
either naïve or NMS mice. Brackets indicate a significant effect of WAS (#p < 0.05), two-way 
RM ANOVA; **p < 0.01 vs. naïve, #, ###p < 0.05, 0.001 vs. baseline, Bonferroni posttest. 
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NMS blunted TNBS and WAS-induced inflammatory gene expression and increased CRF 
receptor expression in the colon 
The impact of NMS, TNBS, and WAS on pro-inflammatory gene expression in the distal 
colon was evaluated by RT-PCR. Treatment with 5mg TNBS induced a trend toward increased 
IL-6 and Artemin mRNA levels in the distal colon of naïve mice, which was not present in NMS 
mice (Figure 3.4A). Indeed, artemin mRNA levels were significantly lower in NMS colon 
compared to naïve, particularly following TNBS treatment (Figure 3.4A). Exposure to 1d WAS 
significantly increased IL-6 mRNA levels in naïve colon and the mRNA levels of IL-6 trended 
toward a significant increase in NMS mice, (p = 0.0525, two-way ANOVA; Figure 3.4B). 
Exposure to 1d WAS had no impact on artemin mRNA levels in the colon of either naïve or 
NMS mice (Figure 3.4B).  
To determine the impact of 1d WAS on peripheral CRF receptor levels, Western blot 
was performed to measure CRF1 and CRF2 protein levels in the distal colon. Protein levels of 
CRF1 in the distal colon were not affected by NMS or 1d WAS (Figure 3.4C). In contrast, 1d 
WAS exposure significantly increased CRF2 protein levels overall, specifically in naïve colon 
post-1d WAS compared to baseline levels (Figure 3.4C). CRF2 protein levels were increased, 
though not significantly, in NMS colon both at baseline and post-1d WAS compared to baseline 
naïve levels (Figure 3.4C). 
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Figure 3.4 Colonic molecular changes after TNBS or WAS treatments 
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Figure 3.4 Colonic molecular changes after TNBS or WAS treatments.   Neonatal maternal 
separation (NMS) alters localized gene and protein expression changes in response to 
inflammation and acute stress. A) Real-time PCR was performed on mRNA from naïve and 
NMS distal colon following saline or 5 mg trinitrobenzene sulfonic acid (TNBS) treatment. A non-
significant increase in interleukin (IL)-6 mRNA levels was observed in naïve colon following 
TNBS treatment, with a corresponding decrease in both IL-6 and artemin mRNA levels in NMS 
colon. B) Exposure to 1d WAS significantly increased IL-6 mRNA levels in naïve colon and 
NMS effected a trend toward increased IL-6 mRNA levels (p = 0.0525, two-way ANOVA). 
Artemin mRNA levels were unaffected by either NMS or WAS. C) Representative Western blots 
are shown for CRF1, CRF2, and corresponding GAPDH protein with bands at 55, 49, and 35 kD, 
respectively. Exposure to 1d WAS had no effect on CRF1 protein levels in either naïve or NMS 
colon. At baseline, CRF2 protein levels were increased in NMS colon and exposure to 1d WAS 
significantly increased CRF2 protein levels, particularly in naïve colon. Brackets indicate a 
significant effect of NMS (*p < 0.05) or WAS (#p < 0.05), two-way RM ANOVA; *p < 0.05 vs. 







Chapter IV: Results: NMS-induced perigenital hypersensitivity and function in 
response to acute adult stress 
Experimental design 
 All experimental naïve and NMS males were subjected to acute water avoidance stress 
(WAS) as adults (20 weeks of age) and assessed for perigenital sensitivity and micturition 
activity 1-day pre-, 1-day post-, and 8-days post-WAS. In vivo experiments were conducted 
within the first six hours of the light cycle. Tissues were collected for in vitro analysis 
immediately following 8d post-WAS reassessment. Control naïve and NMS males were 
undisturbed in their home cages aside from normal husbandry procedures and tissues were 
collected between 10 and 12 weeks of age. 
NMS, but not WAS, induced perigenital hypersensitivity and increased micturition output 
and frequency 
Male mice that did (NMS) or did not (naïve) undergo neonatal maternal separation were 
assessed as adults for perigenital sensitivity or micturition patterning before and following WAS 
exposure. At baseline, NMS mice exhibited a significantly lower perigenital mechanical 
withdrawal threshold than naïve mice (Figure 4.1A). At 1d and 8d post-WAS, NMS males 
continued to exhibit an average perigenital mechanical withdraw threshold that was significantly 
lower than naïve counterparts, although WAS had no significant impact on perigenital sensitivity 
in either group (Figure 4.1A). At baseline, NMS mice had a significantly higher total voided 
volume compared to naïve mice, as well as at 1d post-WAS (Figure 4.1B). No difference in total 
voided volume was observed between naïve and NMS mice at 8d post-WAS; however, NMS 
output was significantly lower than at baseline (Figure 4.1B). NMS mice also had a significantly 
higher number of voids at baseline than naïve mice (Figure 4.1C) and no differences were 
observed in number of voids between naïve and NMS mice at 1d or 8d post-WAS (Figure 4.1C). 
NMS mice had significantly increased fecal output at baseline compared to naïve (Table 4.1). 
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Figure 4.1 Perigenital mechanical withdrawal thresholds and micturition patterns after WAS 
 
 48 
Figure 4.1 Perigenital mechanical withdrawal thresholds and micturition patterns after WAS.  
NMS exposure had a more significant impact on perigenital mechanical sensitivity and 
micturition function than WAS exposure. A) Perigenital mechanical withdraw thresholds were 
significantly lower for male mice exposed to NMS across all time points. B) NMS males 
displayed a significantly higher average for void volume than naïve males at baseline and 1d 
post-WAS. At 8d post-WAS, NMS males averaged smaller void areas compared to their 
respective baseline. C) Significant differences in micturition frequency were only observed at 
baseline, when NMS males averaged more void events compared to naïve males. Brackets 
indicate significant effect of NMS (§§, §§§p < 0.01, 0.001), two-way RM ANOVA; *, **, ***p < 
0.05, 0.01, 0.001 vs. naïve, #p < 0.05 vs. NMS-baseline, Bonferroni posttest (n = 6). 
  
 49 
Table 4.1 Correlation between urinary and gastrointestinal outputs following WAS 
Treatment group Number of pellets 
Correlation with total 
urinary output 
Naïve baseline 1.00  0.45 r = 0.9393, p = 0.0178 
Naïve 1d post-WAS 1.67  0.42 N.D. 
Naïve 8d post-WAS 1.17  0.60 r = 0.9457, p = 0.015 
NMS baseline 3.83  0.70* r = 0.7545, p = 0.0830 
NMS 1d post-WAS 2.00  0.93 r = 0.1887, p = 0.7203 
NMS 8d post-WAS 2.17  0.48 r = -0.02184, p = 0.9672 
The number of pellets were counted following the one-hour micturition analysis test and 
averaged within groups and correlated with total urinary output within mice. NMS significantly 
increased gastrointestinal output compared to naïve mice both overall (p = 0.0164, two-way RM 
ANOVA) and at baseline (* p = 0.003, Fisher’s LSD). Only naïve mice at baseline and 8d post-
WAS displayed a significant correlation between gastrointestinal and urinary output (Pearson’s 
correlation). N.D. = not detected. 
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Interestingly, the total urine output significantly correlated with fecal output at baseline and 8d 
post-WAS only in naïve mice. 
WAS exposure increased sucrose preference for both naïve and NMS males 
 Mice were acclimated to two liquid-choice cages for 48 hours, both bottles filled with 
standard drinking water, before one bottle was replaced with 1% sucrose solution and mice 
were assessed for baseline sucrose preference over 4 days prior to WAS exposure. After 1 hour 
WAS exposure, mice were returned to two-choice liquid preference cages and liquid 
consumption was recorded every 24 hours until 8d post-WAS, but reported in Figure 4.2 every 
48 hours. Naïve and NMS males exhibited similar baseline sucrose preference, and did not 
significantly differ from one another throughout the duration of the study; however, time had a 
significant impact on percent sucrose intake after WAS exposure.  
NMS and WAS had tissue-specific effects on mast cell degranulation inflammatory gene 
expression in urogenital tissues 
 Cryosections of bladder and prostate tissues were stained using toluidine blue-O to stain 
mast cells. Figure 4.3 A-D are representative images of stained prostate tissue. Intact and 
degranulated mast cells were quantified and the degranulated percentage was calculated. 
Consistent with our previous results [137], control NMS, as well as WAS-exposed, males 
displayed significantly higher percentages of degranulated mast cells in both bladder and 
prostate tissues compared to naïve counterparts. Interestingly, WAS exposure did not alter mast 
cell degranulation in bladder tissue, but did significantly increase mast cell degranulation in 
prostate tissue (Figure 4.3E).  
  
 51 




Figure 4.2 WAS exposure increased sucrose preference for both naïve and NMS males.  
Reported baseline sucrose preference was averaged over the 4-day baseline period. Data was 
reported as a percentage of sucrose consumed over a 2-day period to control for a possible 
side preference, as bottles were switched every 24 hours. Sucrose preference for NMS males 
did not differ from naïve controls. Naïve sucrose consumption was significantly increased from 
baseline during the last two 48-hour periods. Bracket indicates significant effect of time (††††p 
< 0.0001); two-way RM ANOVA, #p < 0.05 vs. naïve-baseline, Bonferroni posttest (n = 5-6).  
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Figure 4.3 Urogenital mast cell degranulation after WAS 
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Figure 4.3 Urogenital mast cell degranulation after WAS.   Acidified toluidine blue was used to 
visualize tryptase granules and calculate the percentage of activated/degranulated mast cells in 
cryostat sections of bladder and prostate tissues. Representative photomicrographs are shown 
of toluidine blue-stained sections from naïve (A) and NMS (B) prostate with arrows indicating 
intact (non-degranulated) and arrowheads indicating activated (degranulated) mast cells. Higher 
magnification images from naïve (C) and NMS (D) bladder are shown to illustrate histological 
differences from non-degranulated (C) and degranulated (D) mast cells. E) Bladders from mice 
subjected to NMS with or without WAS exposure exhibited significantly higher percentages of 
degranulated mast cells compared to baseline naïve males; though, WAS exposure did not 
affect bladder mast cell degranulation of naïve mice. Mast cell degranulation percentages were 
found to be increased in prostate tissues of NMS males with or without exposure to WAS, as 
well as naïve males exposed to WAS. Scale bars equal 100µm (A-B) and 40µm (C-D). E: 
Brackets indicate significant effect of NMS (§§§, §§§§p < 0.001, 0.0001), WAS (†p < 0.05), 
and/or NMS-WAS interaction (&&p < 0.01), two-way ANOVA; **, ***p < 0.01, 0.001 vs. naïve-




 Tissue-specific differences were also observed for inflammatory gene expression 
changes in response to NMS and/or WAS exposure. RT-PCR was used to measure interleukin-
6 (IL-6), interleukin-10 (IL-10), stem cell factor (SCF), artemin, nerve growth factor (NGF), and 
monocyte chemoattractant protein-1 (MCP-1) mRNA levels in the bladders and prostates of 
naïve and NMS male mice with or without exposure to WAS. In bladder, WAS had a significant 
effect on increased artemin mRNA levels. NGF expression was significantly affected by NMS, 
as well as an NMS/WAS interaction effect. NMS-WAS males displayed the greatest increase of 
NGF mRNA levels; significantly greater than both naïve and NMS controls. An NMS/WAS 
interaction effect also had a significant impact on increased MCP-1 mRNA levels (Figure 4.4A). 
Similar to bladder values, prostatic IL-6 and IL-10 were not altered by NMS or WAS exposure. 
Expression of SCF was not altered in bladders across all four groups; however, in the prostates, 
decreases in SCF expression were attributed to NMS and NMS/WAS interaction effects. Only 
NMS controls expressed significantly less SCF mRNA than naïve controls. Both NMS control 
and WAS groups displayed significantly lower artemin mRNA levels. For all four groups, NMS 
had a significant impact on decreased prostatic artemin mRNA expression levels, whereas WAS 
had a significant impact on increases in MCP-1 (Figure 4.4B). 
WAS disrupted regulatory gene expression in central structures of the HPA axis 
 To determine the impact of NMS and WAS on gene expression within central structures 
involved in the regulation and output of the HPA axis, mRNA levels of corticotropin releasing 
factor (CRF), urocortin 2 (Ucn2), CRF receptor 1 (CRF1), CRF2, glucocorticoid receptor (GR), 
and mineralocorticoid receptor (MR) in hypothalamus, amygdala, and hippocampus of mice 
were determined by RT-PCR. WAS exposure had a significant impact on decreases in CRF, 
Ucn2, GR, and MR mRNA expression in hippocampi. CRF and MR were particularly low for 
both naïve and NMS WAS-exposed groups, whereas only naïve-WAS males displayed a 
statistically lower level of Ucn2 mRNA than controls (Figure 4.5A). In contrast, WAS had a  
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Figure 4.4 Neuroimmune profiles of urogenital tissues after WAS 
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Figure 4.4 Neuroimmune profiles of urogenital tissues after WAS.   A) Expression levels of 
nerve growth factor (NGF) in the bladders of NMS-WAS males were elevated compared to both 
naïve-baseline and naïve-WAS males. B) Baseline NMS stem cell factor (SCF) and both 
baseline and WAS NMS artemin prostatic gene expression levels were significantly lower than 
respective naïve baselines. Brackets indicate significant effect of NMS (§, §§p < 0.05, 0.01), 
WAS (†p < 0.05), and/or NMS-WAS interaction (&p < 0.05), two-way ANOVA; *, **p < 0.05, 0.01 
vs. naïve-baseline, ##p < 0.01 vs. naïve-WAS, Bonferroni posttest (n = 5). 
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Figure 4.5 Gene expression changes within limbic structures after WAS 
  
 59 
Figure 4.5 Gene expression changes within limbic structures after WAS.   Hypothalamic 
expression of genes associated with the HPA axis were generally downregulated after WAS 
exposure for both naïve and NMS male mice (A). Gene expression in the amygdala, on the 
other hand, was largely upregulated following WAS (B). Gene expression in the hippocampus 
was variably altered; CRF1 was upregulated for both NMS and naïve males after WAS, whereas 
MR expression was increased for baseline NMS and WAS naïve males (C). Bracket indicates 
significant effect WAS (†, ††, ††††p < 0.05, 0.01, 0.0001) and/or NMS-WAS interaction (&, &&p 
< 0.05, 0.01), two-way ANOVA; *, **, ***, ****p < 0.05, 0.01, 0.001, 0.0001 vs. naïve-baseline, 




significant impact on increases in CRF, CRF1, GR, and MR mRNA levels in amygdalae. WAS-
exposed naïve and NMS groups showed significantly higher levels of CRF1, GR, and MR mRNA 
compared to their baseline counterparts (Figure 4.5B). A similar trend was observed for CRF1 
mRNA levels in hippocampi. Increases in GR were statistically attributed to an NMS/WAS 
interaction effect, and MR to both WAS and an interaction effect. Additionally, NMS controls and 
naïve WAS-exposed males exhibited similar increases in MR mRNA expression (Figure 4.5C).   
Stress decreased downstream HPA axis output  
 To complement our central HPA axis-associated mRNA level investigation, we used 
Western blot assay to measure peripheral CRF1 and CRF2 protein expression, as well as ELISA 
analysis to measure serum corticosterone (CORT) concentrations following NMS and/or WAS. 
Bladder CRF1 protein expression was significantly influenced by an NMS/WAS interaction 
(Figure 4.6A). CRF2 protein levels, on the other hand, were not significantly altered in either the 
bladder or the prostate across all four groups (Figure 4.6A and B). Prostates of NMS-WAS mice 
exhibited significantly lower CRF1 concentrations compared to NMS-baseline concentrations, 
but did not significantly differ from either naïve group. The effect of WAS and an NMS-WAS 
interaction effect trended toward significance (p = 0.0616 and p = 0.0846, respectively). When 
analyzed by student’s t-test, NMS-baseline CRF1 concentrations trended toward a significant 
increase compared to naïve-baseline concentrations (p = 0.0769) (Figure 4.6B). Baseline NMS 
males displayed significantly lower concentrations of serum CORT compared to naïve 
counterparts. WAS-exposed groups displayed similar concentrations, but were not significantly 
different from either control group (Figure 4.6C). 
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Figure 4.6 Western blot and serum CORT ELISA analysis after WAS 
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Figure 4.6 Western blot and serum CORT ELISA analysis after WAS.   Representative Western 
blots are shown for CRF1, CRF2, and corresponding GAPDH protein with bands at 55, 49, and 
35kD, respectively. A) Bladders of NMS males exposed to WAS displayed significantly lower 
CRF1 protein levels than those of naïve-WAS males. Bladder CRF2 levels were not observed to 
be altered as a result of NMS nor WAS exposure. B) NMS-WAS prostates also exhibited 
significantly lower CRF1 concentrations compared to NMS-baseline concentrations. The effect 
of WAS and an NMS-WAS interaction effect trended toward significance (p = 0.0616 and p = 
0.0846, respectively). When analyzed by student’s t-test, NMS-baseline CRF1 concentrations 
trended toward a significant increase compared to naïve-baseline concentrations (p = 0.0769). 
For CRF2 concentrations, on the other hand, did not significantly differ across all four groups. C) 
Males subjected to NMS exhibited lower concentrations of serum corticosterone (CORT) 
compared to baseline naïve males. Exposure to WAS did not significantly influence serum 
CORT concentrations. Brackets indicate significant effect of NMS/WAS interaction (&p < 0.05), 
two-way ANOVA, *p <0.05 vs. naïve-baseline, #p <0.05 vs. naïve-WAS, ǂp < 0.05 vs. NMS-
baseline; Bonferroni posttest (n = 5-6). 
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Chapter V: Results: Exercise interventions 
Experimental design 
 We investigated the therapeutic potential of two voluntary wheel running intervention 
paradigms to attenuate neonatal maternal separation (NMS)-induced behavior and 
corresponding molecular changes: 1) early exercise beginning at 4 weeks of age (-Eex) and 2) 
late exercise beginning at 8 weeks of age (-Lex). Early and late sedentary counterparts are 
identified by –Esed and –Lsed, respectively. Early-exercised mice were pair housed with free 
access to a running wheel, whereas late-exercised mice were singly housed with a running 
wheel. Behavior assessments for early-sedentary and -exercised males were performed once at 
8 weeks of age following introduction to cages equipped with running wheels or sedentary living 
conditions. Late-sedentary and -exercised males were assessed for baseline behavioral 
measurements at 8 weeks of age and reassessed at 12 weeks and/or 16 weeks of age. 
Experimental timelines can be found in Figure 5.1. 
Early exercise prevented NMS-induced perigenital hypersensitivity 
 Consistent with our previous results [137], NMS induced perigenital hypersensitivity. For 
both NMS-Esed and baseline NMS-Lex measurements, mice exhibited significantly lower 
withdrawal thresholds in response to mechanical, monofilament stimulation to the scrotum 
compared to their naïve counterparts (Naïve-Esed and Naïve-Lex baseline, respectively) 
(Figure 5.1). Adolescent access to running wheels prevented this observed NMS-induced 
allodynia: Naïve-Eex and NMS-Eex males showed similar withdrawal thresholds that did not 
significantly differ from Naïve-Esed males. Additionally, early exercise and an NMS/exercise 
effect had a significant impact on perigenital mechanical sensitivity (Figure 5.1A). An 
NMS/exercise effect also significantly influenced withdrawal thresholds for late exercised males. 
After 8 weeks of running wheel exposure, Naïve-Lex and NMS-Lex withdrawal thresholds did 
not significantly differ; however, it is difficult to conclude late exercise reversed perigenital  
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Figure 5.1 Exercise paradigms and perigenital mechanical withdrawal thresholds 
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Figure 5.1 Exercise paradigms and perigenital mechanical withdrawal thresholds.   NMS-
induced perigenital mechanical hypersensitivity was prevented and reversed by voluntary wheel 
running. A) Sedentary NMS males displayed significantly lower perigenital withdraw thresholds 
to mechanical stimulation; however, this lowering of threshold was prevented by early voluntary 
wheel running. Pictured above is a schematic representation of the early exercise intervention 
timeline. B) Like sedentary NMS males of the early exercise study, NMS males before late 
exercise intervention exhibited significantly lower perigenital withdrawal thresholds. At the 
completion of 8 weeks of running wheel exposure, NMS thresholds increased to those similar to 
naïve. Experimental timeline can be found above line graph. A: Bracket indicates significant 
effect of exercise (†††p < 0.001) and interaction effect between NMS and early exercise 
exposure (&p < 0.05), two-way ANOVA, *p < 0.05 vs. sedentary naïve, Bonferroni posttest (n = 
9-14). B: Bracket indicates significant NMS-late exercise interaction effect (&p < 0.05), two-way 
RM ANOVA, **p < 0.01 vs. baseline naïve, Bonferroni posttest (n = 7-8). 
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allodynia from these data. Where NMS-Lex thresholds increased over time, Naïve-Lex 
thresholds decreased, but not so much as to be significantly different from their baseline (Figure 
5.1B). 
Voluntary exercise normalized micturition patterns but increased bladder activity and 
output of NMS male mice 
 To measure micturition activity, mice were confined to a sheet of filter paper for one hour 
and the number and area of urine spots were recorded. Because chronic prostatitis/chronic 
pelvic pain syndrome (CP/CPPS) and interstitial cystitis (IC) patients experience up to 60 void 
events in a day in severe cases [60], we hypothesized NMS males to exhibit higher micturition 
frequencies compared to naïve males. Early-sedentary NMS males produced greater volumes 
of urine and void events than sedentary naïve males. We also predicted voluntary wheel 
running to attenuate any variations of micturition function. Following early exercise, NMS and 
naïve mice did not differ in void volume, void frequency, nor from sedentary controls (Figure 
5.2A and C). In contrast, NMS males did not differ from naïve males in micturition output nor 
frequency at baseline, but NMS-Lex males did display significant decreases in both measures at 
12 weeks of age following 4 weeks of running wheel access (Figure 5.2B and D).  
 The filter paper method described above, however, is a crude way to assess bladder 
function. For this reason, we also performed awake filling cystometry in sedentary and early-
exercised naïve and NMS males. At a minimum of seven days after bladder catheter 
implantation surgery, animals were assessed for bladder function for 30 minutes during an 
infusion of saline at a rate of 20 μL/min. There were very few differences among the groups for 
the ten reported parameters. NMS-Eex males displayed significantly lower micturition 
frequencies (Figure 5.3B), but increased void masses (Figure 5.3G) and volumes of infused 
saline per micturition cycle (Figure 5.3H) compared to naïve-Esed males. NMS exposure and 
early exercise experience both had significant impacts on micturition frequency: NMS males  
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Figure 5.2 Micturition patterns following early and late exercise interventions 
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Figure 5.2 Micturition patterns following early and late exercise interventions.   Sedentary NMS 
males exhibited greater void volumes (A) and higher number of void events (C) than sedentary 
naïve counterparts, but NMS and naïve mice did not display significantly different micturition 
patters following early exercise (A and C). At baseline, NMS-Lex males tended to produce 
greater void volumes (B) and higher void frequency (D), but were not statistically different from 
naïve controls at baseline. After 4 weeks of voluntary wheel running, NMS and naïve males 
exhibited similar micturition patterns, and NMS-Lex void output and frequency significantly 
declined compared to their baseline measurements (B and D). A and C: unpaired, two-tailed 
student’s t-test, *p < 0.05 vs. naïve-Esed (n = 6-12). B and D: Brackets indicate significant 
effect of exercise (††p < 0.01) and NMS/exercise interaction (&p < 0.05); two-way RM ANOVA, 
##p < 0.01 vs. NMS-Lex baseline, Bonferroni posttest (n = 8).   
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Figure 5.3 Effect of NMS and/or early exercise on urinary bladder cystometric assessment 
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Figure 5.3 Effect of NMS and/or early exercise on urinary bladder cystometric assessment.   A) 
Sedentary and exercised groups did not differ in the time to the first micturition event. B) 
Micturition frequency for sedentary NMS and exercised naïve males did not significantly differ 
from sedentary naïve males; however, NMS-Eex males did produce significantly fewer 
micturition events in a 30 minute testing period than naïve-Esed males, and NMS and exercise 
did impact frequency across all groups. C) The time between micturition events did not 
significantly differ among the four groups evaluated, but early exercise exposure had a 
significant impact on intermicturition intervals overall. Micturition threshold pressure (D) and the 
maximum pressure recorded (E) did not differ among the groups. F) Pressure amplitude was 
significantly influenced by an NMS-exercise interaction effect. G) NMS-Eex males produced 
significantly higher void masses compared to naïve-Esed males, and early exercise had a 
significant impact across all four groups. H) Moreover, early exercise significantly influenced 
void masses per micturition cycle, and NMS-Eex males exhibited significantly higher void mass 
per cycle than both sedentary groups. I) The maximum infused volume of saline into the bladder 
was significantly dependent on early exercise exposure, but groups did not significantly differ 
from one another. J) The infused volume of saline per cycle was also significantly influenced by 
early exercise, and NMS-Eex males exhibited significantly greater infused volumes per cycle 
than both sedentary groups. Brackets indicate significant effect of NMS (§p < 0.05), early 
exercise (†, ††p < 0.05, 0.01), or NMS/exercise interaction effect (&p <0.05); two-way ANOVA, 
*p < 0.05 vs. naïve-Esed, ǂp < 0.05 vs. NMS-Esed, Bonferroni posttest (n = 3-4). 
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trended toward fewer voids than naïve males, though groups did not significantly differ from one 
another (Figure 5.3B). An NMS-exercise interaction effect was only observed for pressure 
amplitude (Figure 5.3F). Early exercise had the greatest effect on bladder function across all 
groups for intermicturition intervals, maximum void mass, void mass per micturition cycle, 
maximum infused saline volume, and infused volume per micturition cycle (Figure 5.3C, G, H, I, 
and J). 
NMS did not induce anxiety-like nor depression-like behaviors, but may have negatively 
altered reward behavior 
 Because a significant proportion of CP/CPPS patients also suffer from anxiety and 
depression [80, 231-233], we investigated murine elevated plus-maze and sucrose preference 
activity to measure anxiety-like and depression-like behaviors, respectively, before and/or after 
voluntary wheel running for naïve and NMS males.  
The elevated plus-maze is a widely used and validated rodent behavioral assay to 
assess anxiety-like behavior, typically to evaluate the anti-anxiety effects of pharmacological 
agents and to characterize brain regions and mechanisms involved in anxiety-related behavior. 
This test is based on rodents’ natural aversion to open and elevated environments and natural 
spontaneous exploratory behavior to novel environments. We hypothesized sedentary NMS 
males would spend less time in open arms than sedentary naïve males, and voluntary exercise 
would prevent or reverse this perceived anxiety-like behavior as measured by longer bouts of 
exploratory activity in open arms. The time sedentary and baseline NMS males spent in open 
arms of the plus-maze did not significantly differ from their naïve counterparts (Figure 5.4). 
Interestingly, early-exercised mice tended to spend less time in open arms than sedentary 
counterparts (Figure 5.4A) and late-exercised males spent less time in open arms after 8 weeks 
of voluntary wheel running (Figure 5.4B). This observation following late exercise may be 
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Figure 5.4 Anxiety-like behavior measured by elevated plus-maze.  Neither NMS nor voluntary 
wheel running affected anxiety-like behaviors as measured by elevated plus-maze (EPM). A) 
Each group of mice spent significantly more time in closed arms than exploring open arms. B) 
Similarly, no differences in time spent exploring open arms were observed at any time point 
between naïve and NMS males exposed to late exercise. A: Brackets indicate significant effect 
of exercise (†p < 0.05) or plus-maze arm ($$$$p < 0.0001), two-way ANOVA, Bonferroni 
posttest (n = 7-8). B: Bracket indicates significant effect of time (%p < 0.05), two-way RM 
ANOVA, Bonferroni posttest (n = 4-5).  
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 due to a novelty effect; upon introduction to the plus-maze, mice exhibited greater exploratory 
behavior that tapered off with consecutive testing periods. 
 Though we did not observe anxiety-like behavior in our NMS males, we were still 
interested in whether early life stress would influence sucrose preference as a measure of 
anhedonia-like behavior. We hypothesized NMS mice would consume less sucrose solution 
than naïve controls when presented with both standard drinking water and a 1% sucrose 
solution and exercise would prevent or reverse anhedonia-like behavior. NMS did not, however, 
affect sedentary animals’ preference for sucrose (Figure 5.5). Early exercise did not significantly 
impact the percent of sucrose consumed for neither naïve nor NMS males, but naïve-Eex males 
consumed significantly more sucrose solution by volume than their sedentary controls (Figure 
5.5A and B, respectively). Naïve-Lex males exhibited a decrease in sucrose preference 
compared to naïve-Lsed controls, and NMS-Lex males showed a significantly higher preference 
for sucrose than naïve-Lex males (Figure 5.5C). Late-exercised groups did not significantly 
differ in their percent sucrose preference when compared to one another or their respective 
baselines at 8 weeks of age when analyzed by two-way repeated measures ANOVA; however, 
when analyzed with standard two-way ANOVA with Bonferroni posttest, there was a significant 
effect of NMS on sucrose preference (§p <0.05) (Figure 5.5D). 
While decreases in sucrose consumption can be interpreted as depression-like behavior, 
sucrose preference can also indicate an alteration in overall reward behavior. Additionally, 
exercise is considered a natural reward for rodents, and rodents will initiate and sustain running 
activity when presented with uninhibited access to a free running wheel. Interestingly, we 
observed an effect of NMS exposure on running wheel activity for both early and late exercised 
mice (Figure 5.6). Early-exercised NMS male pairs ran shorter average distances per day than 
naïve counterparts (Figure 5.6A). Similarly, singly housed late-exercised NMS males ran shorter 
average distances per day at the end of the six-week study than naïve-Lex males (Figure 5.6B).  
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Figure 5.5 Sucrose preference following early and late exercise paradigms.   NMS did not affect 
sedentary animals’ preference for sucrose. Early exercise did not significantly impact the 
percent of sucrose consumed for naïve nor NMS males (A), but naïve-Eex males consumed 
significantly more sucrose solution by volume than their sedentary controls (B). C) Naïve-Lex 
males exhibited a decrease in sucrose preference compared to naïve-Lsed controls and NMS-
Lex males showed a significantly higher preference for sucrose than naïve-Lex males. D) Late-
exercised groups did not significantly differ in their percent sucrose preference when compared 
to one another or their respective baselines at 8 weeks of age. Brackets indicate significant 
effect of NMS (§p < 0.05) and exercise (†p < 0.05); two-way ANOVA, *p < 0.05 vs. sedentary 
naïve, ##p < 0.01 vs. exercised naïve, Bonferroni posttest (n = 5-27). 
.   
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Figure 5.6 NMS males ran shorter average distances than naïve males.   A) NMS status and an 
NMS-exercise interaction effect had a significant impact on running wheel activity: early-
exercised NMS pairs ran shorter average distances than naïve pairs. NMS pairs ran significantly 
shorter distances after 3 weeks on wheels, but matched naïve distances after 4 weeks of wheel 
running. B) NMS also affected running wheel activity for late-exercised males. Naïve and NMS 
male ran similar average distances during the first wheel of exercise, but NMS males ran 
decreasingly shorter distances over the following 5 weeks of late exercise. Brackets indicate 
significant effect of NMS (§, §§§§p < 0.05, 0.0001) and/or an NMS-exercise interaction (&p < 





These data, sucrose preference and running distance, may indicate a perturbation in reward 
circuitry. It has been argued regular physical activity is the natural state for both rodents and 
humans, so when observing the data through this lens, we see an indication of NMS blunting 
natural pleasure-seeking behavior following exercise that was not observed in sedentary 
controls. 
Exercise prevented and reversed NMS-induced mast cell degranulation in urogenital 
tissues 
 Cryosections of bladder and prostate tissues were stained using toluidine blue-O to stain 
mast cells. Intact and degranulated mast cells were quantified and the degranulated percentage 
was calculated. Consistent with our previous results [137], sedentary NMS tissues exhibited 
increased mast cell degranulation compared to sedentary naïve controls (Figure 5.7). Early and 
late exercise decreased NMS-induced mast cell degranulation. These data suggest voluntary 
running wheel activity is able to prevent and reverse increases in mast cell degranulation 
associated with NMS.  
NMS reduced HPA axis output 
To examine central gene expression changes, hypothalamic, hippocampal, and 
amygdalar issues were collected from early and late sedentary and exercised males for RT-
PCR associated with HPA axis action and regulation. Additionally, we utilized a rodent 
corticosterone (CORT) ELISA kit to measure concentrations of circulating serum CORT as a 
downstream measure of HPA axis output.  
We observed early exercise had a significant impact on hypothalamic increases in CRF2 
gene expression (Figure 5.8A), as well as hippocampal BDNF (Figure 5.8B). Groups did not 
significantly differ from one another when evaluated for expression of CRF, CRF1, Ucn2 
(hypothalamus only), GR, or MR in both hypothalamic and hippocampal tissues of males  
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Figure 5.7 Exercise normalized NMS-induced mast cell degranulation in urogenital tissues.  
Acidified toluidine blue was used to visualize tryptase granules and calculate the percentage of 
activated/degranulated mast cells in cryostat sections of bladder and prostate tissues. A) 
Bladders and prostates from sedentary mice subjected to NMS exhibited significantly higher 
percentages of degranulated mast cells compared to sedentary naïve males, and normalized to 
naïve-Esed levels following early exercise. B) NMS-Lsed bladders exhibited significantly higher 
percentages of degranulated mast cells compared to naïve-Lsed, and were normalized to naïve 
levels following late exercise. Two-way ANOVA; ****p < 0.0001 vs. sedentary naïve, Bonferroni 
posttest (n = 2-4).  
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Figure 5.8 Gene expression changes within limbic structures associated with the HPA axis 
following exercise.  Early exercise had a significant impact on hypothalamic CRF2 gene 
expression (A), as well as hippocampal BDNF (B). Late exercise had a significant effect on 
hippocampal GR and BDNF mRNA levels (D), as well as amygdalar CRF and CRF1 (E). An 
effect of NMS was only observed for hippocampal BDNF (D) and amygdalar CRF1 (E). D) NMS-
Lsed hippocampal MR mRNA was significantly increased compared to naïve-Lsed controls. 
NMS-Lex hippocampal BDNF mRNA was also significantly increased compared to naïve-Lex. 
E) NMS-Lex compared to NMS-Lex displayed greater mRNA levels of CRF and CRF1 in 
amygdala tissue. Sedentary NMS mRNA levels only differed from sedentary naïve levels when 
comparing amygdala CRF1; NMS-Lsed levels were significantly lower than naïve-Lsed. An 
NMS/late exercise interaction effect was observed for amygdalar CRF and CRF1 mRNA levels. 
Brackets indicate significant effect of NMS (§§, §§§p < 0.01, 0.001), exercise (†, ††, ††††p < 
0.05, 0.01, 0.0001), and/or an NMS-exercise interaction effect (&, &&&p < 0.05, 0.001); two-way 
ANOVA, *p < 0.05 vs. sedentary naïve, #p < 0.05 vs. exercised naïve, ǂǂǂ, ǂǂǂǂp < 0.001, 
0.0001 vs. sedentary NMS, Bonferroni posttest (n = 3-8). 
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exposed to early sedentary or exercise conditions (Figure 5.8A and B). HPA axis regulation was 
not altered dramatically, but we did observe lower concentrations of serum CORT for NMS-
Esed males compared to naïve-Esed (Figure 5.9A), though we also saw early exercise lowered 
circulating CORT for both naïve- and NMS-Eex males compared to naïve-Esed males. Overall, 
NMS and exercise had significant impacts on serum CORT concentrations. 
Late exercise had a significant effect on hippocampal GR and BDNF mRNA levels 
(Figure 5.8D), as well as amygdalar CRF and CRF1 (Figure 5.8E). Additionally, an effect of NMS 
was only observed for hippocampal BDNF (Figure 5.8D) and amygdalar CRF1 (Figure 5.8E), 
and an NMS/late exercise interaction effect was observed for amygdalar CRF and CRF1 mRNA 
levels (Figure 5.8E). Neither NMS nor late exercise effected hypothalamic genes. NMS-Lsed 
hippocampal MR mRNA were significantly increased compared to naïve-Lsed controls, and 
NMS-Lex hippocampal BDNF mRNA was also significantly increased compared to naïve-Lex 
(Figure 5.8D). NMS-Lex compared to NMS-Lex displayed greater mRNA levels of CRF and 
CRF1 in amygdala tissue. Sedentary NMS mRNA levels only differed from sedentary naïve 
levels when comparing amygdala CRF1; NMS-Lsed levels were significantly lower than naïve-
Lsed. Though gene expression changes were variable, serum CORT concentrations for 
sedentary NMS males were statistically lower than sedentary naïve controls, consistent with our 
previous results for the early exercise and WAS studies; however, late-exercised NMS males 




Figure 5.9 Serum corticosterone concentrations 
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Figure 5.9 Serum corticosterone concentrations.  A) NMS-Esed, naïve-Eex, and NMS-Eex mice 
exhibited decreasingly lower concentrations of serum corticosterone (CORT) compared to 
sedentary naïve controls. B) Sedentary NMS and late-exercised naïve males displayed lower 
serum CORT concentrations compared to sedentary naïve mice; however, late-exercised NMS 
males displayed a range of serum CORT concentrations that did not significantly differ from the 
other groups. Brackets indicate an effect of NMS (§p < 0.05), exercise (†p < 0.05), or 
NMS/exercise interaction (&&p < 0.01); two-way ANOVA, *, **p < 0.05 vs. sedentary naïve, 
Bonferroni posttest (A: n = 10; B: n = 3-7).   
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Chapter VI: Discussion 
Neonatal maternal separation increases susceptibility to experimental colitis and acute 
stress exposure in male mice 
Exposure to early life stress or trauma is a significant risk factor for developing several 
chronic pain syndromes, including IBS [19-21].  NMS has long been used in rodents to model 
both psychological disturbances and heightened colorectal sensitivity commonly experienced by 
IBS patients. Here, we performed a prolonged NMS paradigm in male mice and provided 
evidence of increased susceptibility of the distal colon to experimental colitis using TNBS and 
acute stress exposure, with accompanying alterations in pro-inflammatory gene/CRF receptor 
expression. 
Rodent models of NMS [175, 234-236] and stress-sensitive strains of rodents [237] have 
been shown to display behaviors indicative of increased anxiety and depression. We previously 
reported a significant decrease in baseline anxiety-like behavior and thermal and mechanical 
thresholds in the hind paw of female NMS mice at baseline [136]. In the current study, male 
NMS mice displayed no significant change in anxiety-like behaviors, yet did have significantly 
shorter thermal withdrawal latencies at baseline. Further exposure to stress, in the form of CRD, 
significantly increased anxiety-like behaviors, similar to the increase observed in female NMS 
mice following vaginal balloon distension [136]. Interestingly, mechanical withdrawal thresholds 
were significantly lower in NMS than naïve mice, post-CRD; however, thermal withdrawal 
latencies were no longer significantly shorter in NMS mice. Exposure to VBD maintained 
decreased hind paw thresholds in our previous study of female NMS mice [136] and sex 
differences in behavioral outcomes following NMS have been previously reported [238, 239] and 
likely contribute to the more robust response in the female NMS mice, compared to the male.   
Increased colorectal sensitivity is a commonly reported outcome of NMS and other 
manipulations of the stress-response system. High-anxiety strains of rats demonstrate 
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significantly greater colorectal sensitivity than non-anxious strains [240-242]. Several studies of 
NMS in rats have reported increased colorectal sensitivity measured as either increased VMR 
[179, 243, 244] or visualized abdominal withdrawal reflexes [185, 239, 245, 246] during CRD. In 
the current study, as well as in our previous study of female NMS mice [247], we did not 
observe any evidence of colorectal sensitivity during CRD in NMS mice at baseline. This is in 
contrast to the significant perigenital mechanical sensitivity exhibited by male NMS mice [248] 
and vaginal [136] and bladder [247] hypersensitivity exhibited by female NMS mice, suggesting 
that the NMS paradigm employed in our studies selectively sensitizes the urogenital system at 
baseline. To our knowledge, only one previous study has investigated colorectal sensitivity in 
NMS mice and reported a significant increase in VMR during CRD [181]. This study used 
BALB/c mice, which have been shown to be a higher anxiety strain than C57Bl/6 mice [249], 
and incorporated NMS from P1-14 with concurrent maternal stress (forced swimming or 
restraint) during the separation period.  
Evidence of increased susceptibility to experimental colitis was observed in NMS mice, 
despite the lack of increased colorectal sensitivity four days after treatment with either 2 or 5mg 
TNBS. Previous studies of NMS in mice reported increased MPO and cytokine production, as 
well as elevated histological scores [250-252]. Here, we demonstrated a greater loss of body 
weight and decreased survival in NMS mice following 5mg TNBS. Colonic MPO activity was 
continuing to increase at 4d post-TNBS in NMS mice, while MPO activity had decreased from its 
peak at 1d post-TNBS in naïve mice, as has been shown previously [253], suggesting an 
exaggerated inflammatory response in NMS mice. Cytokine and growth factor production have 
also been shown to simultaneously increase in rodent models of colitis [254] and ulcerative 
colitis patients have an increased production of pro-inflammatory cytokines [255], as well as 
greater expression of neurotrophic receptors in peripheral nerve endings innervating the 
diseased colon [256]. Naïve mice treated with 5mg TNBS showed a trend toward increased 
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colonic IL-6 mRNA levels, which was not apparent in NMS colon. Two growth factors, nerve 
growth factor (NGF) and artemin, have been shown to dramatically increase following acute 
colitis in rodents [257-259]. Here we observed a slight, but not significant, increase in artemin 
mRNA levels in naïve mice following 5mg TNBS and NMS colon actually showed a significant 
decrease in artemin mRNA levels compared to naïve colon. Colonic NGF mRNA was not 
significantly altered by 5mg TNBS in either naïve or NMS mice (data not shown).  
Symptom onset or exacerbation is often triggered by stress in patients suffering from IBS 
[12]. Clinically, peripheral administration of CRF has been shown to reduce the threshold to 
CRD and increase rectal compliance in human subjects [260]. Likewise, administration of CRF1 
antagonist produced inhibitory effects within the emotional-arousal circuit of female IBS patients 
that were anticipating a painful stimulus [24]. A single exposure to WAS has previously been 
shown to increase VMR in NMS rats, but not in naïve rats [31, 32, 179], whereas repeated 
exposure to WAS has been shown to significantly increase colorectal sensitivity in non-NMS 
rats [261, 262]. In the current study, colorectal sensitivity in NMS mice was only increased by a 
single exposure to WAS and not following chronic exposure. The VMR of naïve mice was 
completely unaffected by either WAS treatment. Considering the paucity of studies investigating 
the impact of NMS or WAS on colorectal sensitivity in mice, it is possible that these stressors do 
not have the same impact across species. This theory is supported by our previous studies 
showing an impact of NMS on urogenital sensitivity in mice [136, 247, 248], which has largely 
not been observed in rat models of NMS. 
Rodents exposed to NMS demonstrate increased growth factor and cytokine expression, 
including NGF, IL-6, IL-1, IL-2, IL-4, IL-10, and interferon (IFN)- [26-29], as well as infiltration 
of mast cells [30-32], in the distal colon, all of which can sensitize peripheral nociceptors and 
enhance visceral perception [26-29, 33]. Mast cell infiltration and hypertrophy of sensory 
innervation has also been reported in biopsies from patients with IBS [34-36]. A single exposure 
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to WAS elicited a significant increase in IL-6 mRNA levels in naïve colon, confirming that, 
despite the lack of physiological evidence, 1d WAS exposure did indeed significantly impact 
naïve colon. The mRNA levels of IL-6 in NMS mice trended toward a significant increase; 
however, the blunted effect of WAS on increasing IL-6 expression in NMS colon further 
suggests that neuroimmune responses to stress exposure are imbalanced following NMS 
exposure in mice.  
A potential role for CRF in mediating comorbidity between psychological and chronic 
pain disorders has been investigated in both clinical and preclinical settings. Over-activity of 
central CRF1 signaling has been proposed to contribute towards comorbid anxiety/depression in 
female diarrhea-predominant IBS patients [23]. Associations between anxiety and voiding 
disorders have also been reported [90] and interstitial cystitis (IC) patients with fibromyalgia, 
chronic fatigue syndrome, or rheumatoid arthritis had higher mean afternoon cortisol levels and 
increased pain during bladder filling than IC patients with no additional diagnoses [91]. In a 
study using repeated WAS exposure to induce colorectal sensitivity in non-NMS rats, treatment 
with a CRF1 antagonist treatment prior to, but not following, WAS prevented an increase in VMR 
[263]. However, treatment with astressin, a non-selective CRF1/ CRF2 antagonist, only reduced 
the effect of WAS, suggesting that activation of CRF2 mediates colonic hypoalgesia. This 
observation is supported by studies showing that activation of CRF2 decreases CRF1-driven 
colorectal hypersensitivity [264, 265], c-Fos induction in the colonic myenteric ganglia, and 
increased colonic motility [266]. In the current study, protein levels of CRF2 were increased in 
NMS colon at baseline, similar to previous studies investigating mRNA levels in both male NMS 
rats [113] and female NMS mice [136]. The protein levels of CRF2 were also increased in naïve 
colon following a single exposure to WAS. Urocortin signaling through CRF2 has been shown to 
increase IL-6 expression/release in cardiomyocytes and aortic smooth muscle cells [267, 268], 
and could be playing a similar mechanistic role here. The baseline increase in CRF2 protein in 
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NMS colon may have primed the response to WAS, thereby increasing colorectal sensitivity, 
compared to naïve mice. Further investigation will be required to understand how the CRF 
receptors mediate colorectal sensitivity in mice and how stress at both early and late stages of 
life will impact their expression and activation patterns. 
Conclusions 
We have tested the hypothesis that early life stress in male mice increases susceptibility 
to experimental colitis and adult stress exposure.  Mice exposed to NMS show increased 
thermal hind paw sensitivity at baseline with an increase in anxiety-like behaviors and 
mechanical hind paw sensitivity following exposure to CRD. Intracolonic instillation of TNBS 
induces a dose-dependent loss in body weight and decreased survival rate in NMS mice. A 
single exposure to WAS, but not a 7-day repeated exposure, increased the VMR during CRD of 
NMS mice, and revealed evidence of improper neuroimmune response within the colon. Taken 
together, these results suggest that NMS in mice disrupts inflammatory- and stress-induced 
gene expression in the colon, potentially contributing towards an exaggerated response to 
specific stressors later in life. 
Water avoidance stress did not compound phenotypes associated with neonatal 
maternal separation in male mice 
NIH designated category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) 
and interstitial cystitis/painful bladder syndrome (IC/PBS) share overlapping symptomology and 
are frequently co-diagnosed [63, 65]. For many of these patients, stress often triggers or 
exacerbates symptoms and share a history of early life stress [232, 269]. Early life stress or 
experiences of adverse childhood events have been associated with improper functioning of the 
hypothalamic-pituitary-adrenal (HPA) axis and can serve as risk factors for functional pain 
disorders in adulthood [21, 105, 232, 269]. Here we have provided the first evidence of early life 
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stress (NMS)-induced perigenital mechanical sensitivity of male mice that was not, however, 
exacerbated by acute adult stress, in the form of water avoidance stress (WAS). Experience of 
acute adult stress did not increase urine output of NMS-exposed mice, but did enhance 
neuroimmune profiles in both bladder and prostate of naïve mice, though NMS had a more 
significant impact on mast cell degranulation. These data suggest that early life stress 
contributes to a painful phenotype that is variably affected by acute stress in adulthood. 
 CP/CPPS and IC/PBS are characterized by chronic, idiopathic pelviperineal referable 
pain with or without urinary symptoms such as urgency, frequency, and nocturia [39, 65]. It has 
been estimated that as high as 17% of CP/CPPS patients suffer from comorbid IC/PBS [63]. 
These patients frequently report the onset or worsening of symptoms during periods of 
heightened stress [11, 81, 99, 100]. Additionally, a proportion of these individuals also report a 
history of adverse childhood events, and exposure to early life stress or trauma has been shown 
to be a significant risk factor developing HPA axis abnormalities and associated chronic pain 
syndromes [21, 105, 269]. NMS in rodents has been used for several decades as a model of 
early life stress that significantly impacts the functioning of the HPA axis [168-171]. We have 
repurposed this well-validated model for colonic sensitivity to investigate perigenital sensitivity in 
male mice as a novel model for CP/CPPS with comorbid IC/PBS and mood disturbances. In a 
previous study, we reported a significant decrease in mechanical withdrawal thresholds in the 
perigenital region of male NMS mice at baseline [137]. In the current study, male NMS mice 
similarly displayed significantly lower withdrawal thresholds compared to naïve controls at 
baseline, but this perigenital allodynia was not exacerbated by acute WAS exposure. 
Furthermore, WAS did not enhance micturition output observed in NMS males compared to 
naïve controls. We also observed NMS mice to display increased gastrointestinal output 
compared to naïve, overall and at baseline. A correlation between gastrointestinal and total 
urinary output was only observed for naïve mice at baseline and 8d post-WAS. 
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 As CP/CPPS and IC/PBS patients commonly suffer from depression [79, 82-84, 87, 88], 
we were interested in investigating sucrose preference as a measure of anhedonia-like 
behavior. We did not, however, observe any differences in sucrose preference between NMS 
and naïve mice. We also hypothesized WAS exposure would reduce sucrose consumption in 
NMS males. We did not see a decrease in NMS sucrose preference; in fact, both NMS and 
naïve males increased their consumption from baseline following WAS exposure. Finding no 
differences at baseline may be due to strain choice; C57BL/6 mice have been reported to be 
stress-resilient to social-defeat, repeated footshock, and cat urine exposure [270-273]. For 
future studies it may be prudent to select a less resilient strain. Another member of the lab has 
had preliminary success inducing behavioral measurements of anhedonia with concomitant 
hypersensitivity using repeated footshock in A/J mice (The Jackson Laboratory).  A/J mice 
have been shown to exhibit more anxiety-like and depression-like behaviors [274], but is an 
inbred species more commonly used to model cancer and carcinogenic testing. 
Increased mast cell infiltration and degranulation has been implicated in CP/CPPS as 
well as IC/PBS [43, 54, 71, 72, 74, 94, 148-156, 158, 160, 161, 163-165]. Previous work from 
our lab has shown neonatal maternal separation to influence mast cell degranulation in male 
C57Bl/6 mice [137]. Interestingly, WAS resulted in increased mast cell degranulation in only the 
prostates, not bladders, of naïve males compared to unstressed controls, though NMS had a far 
more significant impact on mast cell degranulation in both bladder and prostate tissues. Tissue-
specific differences were also observed for inflammatory gene expression changes in response 
to NMS and/or WAS exposure. In bladder, increases in NGF expression were significantly 
affected by NMS, as well as an NMS/WAS interaction effect. NMS-WAS males displayed the 
greatest increase of NGF mRNA levels; significantly greater than both naïve and NMS controls. 
An NMS/WAS interaction effect also had a significant impact on increased MCP-1 mRNA levels. 
Similar to bladder values, prostatic IL-6 and IL-10 were not statistically altered by NMS or WAS 
exposure. We had expected both IL-6 and IL-10 to be elevated based on the findings of other 
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investigators [58, 59, 74]. Expression of SCF was not altered in bladders across all four groups; 
however, in the prostates, decreases in SCF expression were attributed to NMS and NMS/WAS 
interaction effects. Only NMS controls expressed significantly less SCF mRNA than naïve 
controls. WAS had a significant impact on increases in MCP-1.  
Increases in NGF are consistent with other studies and clinical presentation, though 
investigating levels of mast cell tryptase should also be a priority for future studies; tryptase has 
been shown to be elevated in IC/PBS urine [74, 163-165] and CP/CPPS prostatic secretions 
[43]. Elevated mast cell tryptase in CP/CPPS suggests mast cells are present in the prostate 
and in a state of activation [43]. Increased NGF expression has been previously noted in 
IC/PBS urine [74, 163-165], CP/CPPS prostatic secretions, and EAP models of prostatitis [57, 
166]. Mast cell tryptase and NGF have been considered the most promising biomarkers of 
CP/CPPS, and NGF’s prominent role in IC/PBS further strengthens the hypothesis that 
CP/CPPS and IC/PBS are different manifestations of the same underlying disorder. NGF can be 
released from mast cells, as well as contribute to degranulation [43]. This is significant because 
there is evidence that nerves and mast cells may communicate in an NGF-dependent manner 
[275]. NGF is a potential mediator of peripheral sensitization mechanisms underlying CP/CPPS 
[43, 276] because of its role in generation and potentiation of pain following tissue injury and 
inflammation [277]. NGF has become a therapeutic target, yielding marginal success; 
therapeutic inhibition of NGF decreased pain-like behavior responses in a number of animal 
models of visceral pain [278], as well as IC/PBS in humans [279]. 
To determine the impact of NMS and WAS on gene expression within central structures 
involved in the regulation and output of the HPA axis, mRNA levels of corticotropin releasing 
factor (CRF), urocortin 2 (Ucn2), CRF receptor 1 (CRF1), CRF2, glucocorticoid receptor (GR), 
and mineralocorticoid receptor (MR) in hypothalamus, amygdala, and hippocampus of mice 
were determined by RT-PCR. WAS exposure had a significant impact on decreases in CRF, 
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Ucn2, GR, and MR mRNA expression in hippocampi. CRF and MR were particularly low for 
both naïve and NMS WAS-exposed groups, whereas only naïve-WAS males displayed a 
statistically lower level of Ucn2 mRNA than controls. In contrast, WAS had a significant impact 
on increases in CRF, CRF1, GR, and MR mRNA levels in amygdalae. WAS-exposed naïve and 
NMS groups showed significantly higher levels of CRF1, GR, and MR mRNA compared to their 
baseline counterparts. A similar trend was observed for CRF1 mRNA levels in hippocampi. 
Increases in GR were statistically attributed to an NMS/WAS interaction effect, and MR to both 
WAS and an interaction effect. Additionally, NMS controls and naïve WAS-exposed males 
exhibited similar increases in MR mRNA expression.  When these data are taken together with 
the changes in peripheral CRF1 and lower serum CORT concentrations, we conclude our NMS 
males exhibit something resembling hypocortisolism, similar to studies in children exposed to 
severe deprivation, neglect, or abuse reporting lower baseline levels of glucocorticoids [112, 
125], and WAS induces changes to gene expression that may decrease HPA axis output. In 
human studies, it has been hypothesized that lower basal glucocorticoid levels may be due to a 
downregulation of the HPA axis at the level of the pituitary in response to chronic drive of CRF 
from the hypothalamus [126], or target tissue hypersensitivity to glucocorticoids [127]. Stress 
exposure typically promotes CRF release in the central amygdale [130]. Chronic glucocorticoid 
exposure increases expression of CRF mRNA [131, 132], suggesting a stress sensitization that 
may be involved in the development of stress-related pathologies [120]. Our reported mRNA 
levels, however, were not significantly different for NMS amygdale, and we saw only marginal 
increases in CRF expression for both WAS groups compared to naïve controls. 
Conclusions 
We have tested the hypothesis that early life stress in male mice increases perigenital 
hypersensitivity, micturition pattern, and depression-like behavior, as well as possible 
exacerbation by acute adult stress. Mice exposed to NMS show increased perigenital 
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mechanical sensitivity at baseline, but did not worsen following WAS. Baseline micturition 
patterning assays showed NMS males producing a greater number of void and greater urine 
output; these measurements were dramatically lower after WAS, but this may in part be due to a 
loss of novelty/exploratory behavior during the micturition testing period. We also failed to 
observe any indications of altered mood behavior. Most promising were data indicating 
enhanced neuroimmune profiles, central gene expression changes, and peripheral HPA axis 
output measures following both NMS and WAS exposure. Though our data did not mirror the 
majority of previous studies, taken together, these results suggest that NMS in male mice 
induces perigenital hypersensitivity, enhances mast cell degranulation and inflammatory gene 
expression, and results in decreased HPA axis output; though WAS did not exacerbate pain-like 
behaviors, WAS did impact mast cell degranulation and gene expression changes associated 
with stress sensitization. 
Exercise prevented and reversed prominent neonatal maternal separation-induced 
perigenital hypersensitivity and urogenital tissue mast cell degranulation 
 Exercise and regular physical activity can significantly improve symptom severity in 
patients with IBS [193, 195-199], fibromyalgia [200-202], and depression and/or anxiety [203-
205]. Voluntary physical activity can favorably influence brain plasticity by facilitating 
neurogenerative, neuroadaptive, and neuroprotective processes [187]. Chronic voluntary 
physical activity also attenuates neural responses to stress in brain circuits responsible for 
regulating peripheral sympathetic activity; mitigating several harmful consequences of acute 
stress exposure [187]. We first observed NMS-induced perigenital hypersensitivity, consistent 
with our previous studies [137], to be prevented or reversed by running wheel activity. Here we 
provide the first evidence of the efficacy of voluntary wheel running as a potential therapeutic 
intervention to attenuate the painful phenotype induced by early life stress exposure (NMS) as 
well as alterations to micturition patterning, mast cell degranulation, and HPA axis output. We 
 97 
are confident these improvements in perigenital sensitivity and mast cell degranulation are 
attributable to physical activity rather than enhanced environmental enrichment of the running 
wheel; Nyhuis et al. previously reported that only exercised rats showed rapid glucocorticoid 
habituation to repeated audiogenic stress [280]. For future studies, however, it may be 
advantageous to include locked wheels in sedentary males’ home cages to control for the 
added enrichment. 
Increased urinary urgency and frequency are characteristic symptoms of IC/PBS and, in 
some cases, CP/CPPS. Similar to our previous results, NMS males exhibited increased void 
frequency and urine output. Micturition patterns were returned to naïve levels following both 
early exercise and late exercise. However, both naïve and NMS void measurements dropped 
sharply when reassessed. This noted change in behavior may be due to a lack of novelty; when 
mice were reintroduced to the testing setup, exploratory behavior decreased. To more 
accurately measure bladder function, a catheter was implanted into the dome of the bladder and 
subcutaneously tunneled and exteriorized at the base of the neck for the purposes of performing 
awake, filling cystometry. Schwartz et al. previously reported increased urinary voiding 
frequency for a murine model of chronic prostatitis by zymosan injection to the prostate [58]. In 
our NMS model, however, we observed a trend toward fewer void events, as well as greater 
threshold pressures, greater pressure amplitudes, and greater volumes and masses of void 
events, especially following early exercise. Additional studies need to be performed to increase 
statistical strength and determine how cystometric analysis differ from behavioral micturition 
testing. It is likely that voluntary voiding, particularly in a prey species, is regulated by more 
operant mechanisms than cystometric measurements can provide. However, altering our 
surgical techniques to increase reproducibility and diminish external input, such as stabilizing 
the catheter at the base of the neck to decrease movement of the catheter at the bladder and 
providing a sound-proof test space, will provide more consistent data.  
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In rodents, exercise has been shown to attenuate both anxiety- and depression-related 
behaviors in NMS rats by normalizing gene expression changes within limbic structures 
regulating HPA axis output [188, 189]. Chronic wheel running in rats prevents behavioral 
consequences of uncontrollable stress, including features of depression and anxiety [187, 190-
192]. Free access to running wheels also normalized hippocampal GR and BDNF mRNA levels 
in NMS rats [188]. BDNF has been reported to be decreased when glucocorticoids are elevated 
during stress [281]. In a separate study, exercised NMS rats exhibited a significant decrease in 
depressive behavior compared to sedentary counterparts [189]. We, however, did not observe 
anxiety-like nor depression-like behaviors. Again, this may be due to the strain choice. However, 
improvements can be made to EPM and sucrose preference protocol. Arabo et al. concluded 
from their studies that rodents do not immediately behave according to the approach-avoidance 
conflict when forcibly exposed to the maze and the first 2 minutes of a 5 minute EPM test is not 
accurate anxiety-like behavior. Another type of maze, such as a zero maze, could also be 
employed. As for sucrose preference, our mice were acclimated for 24 hours then tested for 
sucrose preference for 24 hours during our exercise studies (this is not the case for our WAS 
studies). Establishing a baseline of sucrose preference for a minimum of 4 days prior to sucrose 
preference data collection, may give us a clearer picture of depression-like behavior, if it is 
present. Moreover, collecting sucrose data for 2 days, rather than 1, and switching the position 
of the bottles can control for a potential side preference of the mouse.  
Activation of CRF1 and CRF2 work in opposition of one another, driving and dampening 
HPA output, respectively [114-117]. We had expected NMS to decrease HPA axis output, 
similar to the mRNA levels observed for our NMS controls in our WAS study. We did not 
observe many changes in gene expression attributed to NMS, but we did observe that early 
exercise had a significant impact on hypothalamic increases in CRF2 gene expression, as well 
as hippocampal BDNF. HPA axis regulation was not altered dramatically, but we did observe 
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lower concentrations of serum CORT for NMS-Esed males compared to naïve-Esed, consistent 
with our previous studies, though we also saw early exercise lowered circulating CORT for both 
naïve- and NMS-Eex males compared to naïve-Esed males. Overall, NMS and exercise had 
significant impacts on serum CORT concentrations. 
Late exercise had a significant effect on hippocampal GR and BDNF mRNA levels, as 
well as amygdalar CRF and CRF1. Additionally, an effect of NMS was only observed for 
hippocampal BDNF and amygdalar CRF1, and an NMS/late exercise interaction effect was 
observed for amygdalar CRF and CRF1 mRNA levels. Neither NMS nor late exercise affected 
hypothalamic gene expression levels. NMS-Lsed hippocampal MR mRNA were significantly 
increased compared to naïve-Lsed controls, and NMS-Lex hippocampal BDNF mRNA was also 
significantly increased compared to naïve-Lex. NMS-Lex compared to NMS-Lex displayed 
greater mRNA levels of CRF and CRF1 in amygdala tissue. Sedentary NMS mRNA levels only 
differed from sedentary naïve levels when comparing amygdala CRF1; NMS-Lsed levels were 
significantly lower than naïve-Lsed. Though gene expression changes were variable, serum 
CORT concentrations for sedentary NMS males were statistically lower than sedentary naïve 
controls, consistent with our previous results for the early exercise and WAS studies; however, 
late-exercised NMS males displayed a greater range of concentrations, contributing to the 




Here we provided evidence early and late exercise can prevent and reverse NMS-
induced perigenital allodynia, as well as normalize mast cell degranulation in urogenital tissues. 
We did not observe evidence of comorbid mood disorders, specifically anxiety-like and 
depression-like behaviors. NMS did not significantly impact central gene expression in CRF-
responsive brain regions, but serum CORT concentrations are consistent with our previous 
results of NMS inducing a state of lower basal serum corticosterone concentration. Further 
improvements and in vitro analysis should be conducted to better elucidate the underlying 
mechanism of the observed hypersensitivity, but also its resolution though exercise intervention. 
Western blot analysis of urogenital tissues, immunohistochemistry, pharmacological stabilization 
of mast cells, and gene expression analysis of urogenital tissues for neuroimmune profile will be 
invaluable in furthering these efforts. 
Final conclusions 
Idiopathic functional pelvic pain disorders, specifically IBS, CP/CPPS, and IC/PBS, are 
common, debilitating, and frequently co-diagnosed. A subset of patients report a history of 
abuse or neglect during early childhood, which is a critical period of nociceptive and stress-
resilience programming, as well as a triggering or worsening of symptoms during periods of 
heightened stress.  The mechanisms of chronic visceral pain are not well understood, in part 
due to its diffuse and poorly localized nature, often confused or overlapping between two 
visceral organs. Additionally, the diverse nature of visceral pain is compounded by multiple 
factors, including psychosocial stress, sexual dimorphism, and genetic and/or environmental 
predisposition. These multiple contributing factors make treatment and research efforts, 
especially the development and study of relevant animal models, challenging. However, visceral 
hypersensitivity has been recognized to occur due to (1) peripheral sensitization, (2) central 
sensitization, and (3) dysregulation of descending pathways that modulate spinal nociceptive 
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transmission [2]. Of note is the HPA axis; comorbid mood and pelvic pain disorders have been 
associated with disruption in proper functioning and limbic regulation of the HPA axis, which 
utilizes CRF to regulate stress response and influence the perception of pain [21, 101-105]. 
Furthermore, increased mast cell infiltration and/or activation has been implicated in IBS, 
CP/CPPS, and IC/PBS [34-36]. Further understanding of the development and maintenance of 
chronic pelvic pain will better inform appropriate assessment and interventions, thus leading to 
improved physical and psychological function. Due to the shared symptomology and 
comorbidity of functional pelvic pain disorders, it would be most advantageous to develop a 
reliable animal model depicting multiple conditions.  
This work utilized a male mouse model of early life stress by neonatal maternal 
separation to conclude: 1) NMS in male mice disrupts inflammatory- and stress-induced gene 
expression in the colon, potentially contributing towards an exaggerated response to specific 
stressors later in life; 2) NMS in male mice induces perigenital hypersensitivity, enhances mast 
cell degranulation and inflammatory gene expression in urogenital organs, and results in 
decreased HPA axis output; furthermore, water avoidance stress enhanced mast cell 
degranulation and gene expression changes associated with stress sensitization, but did not 
exacerbate nociceptive behaviors; and 3) early and late exercise can prevent and reverse NMS-
induced perigenital allodynia, as well as normalize mast cell degranulation in urogenital tissues.  
Further improvements and in vitro analysis should be conducted to better elucidate the 
underlying mechanism of the observed hypersensitivity, but also its resolution though exercise 
intervention. For instance, BDNF can be more sensitively measured from serum using ELISA, 
while GTPS binding assays can be used to evaluate ligand affinity for CRF1 and/or CRF2.  
Western blot analysis of urogenital tissues, immunohistochemistry, pharmacological stabilization 
of mast cells, and gene expression analysis of urogenital tissues for neuroimmune profile will be 
invaluable in furthering these efforts. Pharmacological inhibition of CRF1 or genetic knock 
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out/down could also be performed to further investigate the relationship between NMS and HPA 
axis activity within this model in these contexts. Supplementary study of the impact of NMS on 
reward behavior and CNS signaling, specifically the dopaminergic reward pathway, is a 
particularly interesting thread of investigation.  
We intended to identify key modulators that could serve as potential pharmacological 
targets, as well as provide the first pre-clinical evidence on the efficacy of an exercised-based 
therapeutic intervention, an easily translatable and inexpensive intervention. Positive results 
from this study could potentially be applied to other functional pain disorders linked to early life 
stress, including fibromyalgia and migraine, thus broadening the impact of our findings. The 
benefits/impact of the work would be improving the quality of life of individuals suffering from 
these debilitating mood and pain disorders, as well as decreasing the overall annual expense of 
treatment for these comorbid disorders. 
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